{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["Mice", "."], "sentence": "Mice .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S2", "tokens": ["Cbfb", "F", "/", "F", "CD4", "-", "cre", "and", "Foxp3", "GFP", "mice", "have", "previously", "been", "described", "(", "Bettelli", "et", "al", ".", ",", "2006", ";", "Naoe", "et", "al", ".", ",", "2007", ")", "."], "sentence": "Cbfb F / F CD4 - cre and Foxp3 GFP mice have previously been described ( Bettelli et al . , 2006 ; Naoe et al . , 2007 ) .", "event_mentions": [], "entity_mentions": [{"id": "T1", "text": "Cbfb", "entity_type": "Protein", "start": 0, "end": 0}, {"id": "T2", "text": "CD4", "entity_type": "Protein", "start": 4, "end": 4}, {"id": "T3", "text": "cre", "entity_type": "Protein", "start": 6, "end": 6}, {"id": "T4", "text": "Foxp3", "entity_type": "Protein", "start": 8, "end": 8}, {"id": "T5", "text": "GFP", "entity_type": "Protein", "start": 9, "end": 9}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S3", "tokens": ["Cd45.1", "and", "Rag2", "-", "/", "-", "mice", "were", "purchased", "from", "Jackson", "ImmunoResearch", "Laboratories", "and", "Taconic", ",", "respectively", "."], "sentence": "Cd45.1 and Rag2 - / - mice were purchased from Jackson ImmunoResearch Laboratories and Taconic , respectively .", "event_mentions": [], "entity_mentions": [{"id": "T6", "text": "Cd45.1", "entity_type": "Protein", "start": 0, "end": 0}, {"id": "T7", "text": "Rag2", "entity_type": "Protein", "start": 2, "end": 2}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S4", "tokens": ["For", "the", "in", "vivo", "Foxp3", "conversion", "assay", ",", "naive", "CD4", "+", "T", "cells", "from", "Cbfb", "CD4", "-", "cre", "or", "control", "mice", "(", "harboring", "a", "Foxp3", "-", "IRES", "-", "GFP", "allele", ")", "were", "adoptively", "transferred", "into", "Rag", "-", "deficient", "mice", "."], "sentence": "For the in vivo Foxp3 conversion assay , naive CD4 + T cells from Cbfb CD4 - cre or control mice ( harboring a Foxp3 - IRES - GFP allele ) were adoptively transferred into Rag - deficient mice .", "event_mentions": [{"id": "E1", "event_type": "Negative_regulation", "trigger": {"text": "deficient", "start": 37, "end": 37}, "arguments": [{"entity_id": "T15", "text": "Rag", "role": "Theme"}]}], "entity_mentions": [{"id": "T8", "text": "Foxp3", "entity_type": "Protein", "start": 4, "end": 4}, {"id": "T9", "text": "CD4", "entity_type": "Protein", "start": 9, "end": 9}, {"id": "T10", "text": "Cbfb", "entity_type": "Protein", "start": 14, "end": 14}, {"id": "T11", "text": "CD4", "entity_type": "Protein", "start": 15, "end": 15}, {"id": "T12", "text": "cre", "entity_type": "Protein", "start": 17, "end": 17}, {"id": "T13", "text": "Foxp3", "entity_type": "Protein", "start": 24, "end": 24}, {"id": "T14", "text": "GFP", "entity_type": "Protein", "start": 28, "end": 28}, {"id": "T15", "text": "Rag", "entity_type": "Protein", "start": 35, "end": 35}, {"id": "T253", "text": "deficient", "entity_type": "Negative_regulation", "start": 37, "end": 37}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["5", "x", "106", "cells", "were", "used", "per", "transfer", "."], "sentence": "5 x 106 cells were used per transfer .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S6", "tokens": ["6", "wk", "later", ",", "TCRbeta", "+", "CD4", "+", "gated", "cells", "from", "the", "spleen", ",", "mesenteric", "lymph", "node", "(", "MLN", ")", ",", "and", "lamina", "propria", "of", "the", "small", "intestine", "were", "analyzed", "for", "Foxp3-GFP", "expression", "."], "sentence": "6 wk later , TCRbeta + CD4 + gated cells from the spleen , mesenteric lymph node ( MLN ) , and lamina propria of the small intestine were analyzed for Foxp3-GFP expression .", "event_mentions": [{"id": "E2", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 32, "end": 32}, "arguments": [{"entity_id": "T18", "text": "Foxp3-GFP", "role": "Theme"}]}], "entity_mentions": [{"id": "T16", "text": "TCRbeta", "entity_type": "Protein", "start": 4, "end": 4}, {"id": "T17", "text": "CD4", "entity_type": "Protein", "start": 6, "end": 6}, {"id": "T18", "text": "Foxp3-GFP", "entity_type": "Protein", "start": 31, "end": 31}, {"id": "T254", "text": "expression", "entity_type": "Gene_expression", "start": 32, "end": 32}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["All", "analyses", "and", "experiments", "were", "performed", "on", "animals", "at", "6-8", "wk", "of", "age", "."], "sentence": "All analyses and experiments were performed on animals at 6-8 wk of age .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["Animals", "were", "housed", "under", "specific", "pathogen-free", "conditions", "at", "the", "animal", "facility", "of", "the", "Skirball", "Institute", ",", "and", "experiments", "were", "performed", "in", "accordance", "with", "approved", "protocols", "for", "the", "New", "York", "University", "Institutional", "Animal", "Care", "and", "Usage", "Committee", "."], "sentence": "Animals were housed under specific pathogen-free conditions at the animal facility of the Skirball Institute , and experiments were performed in accordance with approved protocols for the New York University Institutional Animal Care and Usage Committee .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S9", "tokens": ["Isolation", "of", "PBMCs", ",", "CD4", "+", "T", "cells", ",", "and", "culture", "conditions", "."], "sentence": "Isolation of PBMCs , CD4 + T cells , and culture conditions .", "event_mentions": [], "entity_mentions": [{"id": "T19", "text": "CD4", "entity_type": "Protein", "start": 4, "end": 4}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S10", "tokens": ["Human", "PBMCs", "were", "isolated", "by", "Ficoll", "(", "Biochrom", ")", "density", "gradient", "centrifugation", "and", "CD4", "+", "T", "cells", "were", "then", "isolated", "using", "the", "Dynal", "CD4", "+", "Isolation", "kit", "(", "Invitrogen", ")", "according", "to", "the", "manufacturer", "'s", "instructions", "."], "sentence": "Human PBMCs were isolated by Ficoll ( Biochrom ) density gradient centrifugation and CD4 + T cells were then isolated using the Dynal CD4 + Isolation kit ( Invitrogen ) according to the manufacturer 's instructions .", "event_mentions": [], "entity_mentions": [{"id": "T20", "text": "CD4", "entity_type": "Protein", "start": 13, "end": 13}, {"id": "T21", "text": "CD4", "entity_type": "Protein", "start": 23, "end": 23}, {"id": "T22", "text": "kit", "entity_type": "Protein", "start": 26, "end": 26}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S11", "tokens": ["The", "purity", "of", "CD4", "+", "T", "cells", "was", "initially", "tested", "by", "flow", "cytometry", "and", "was", ">", "/", "=95", "%", "."], "sentence": "The purity of CD4 + T cells was initially tested by flow cytometry and was > / =95 % .", "event_mentions": [], "entity_mentions": [{"id": "T23", "text": "CD4", "entity_type": "Protein", "start": 3, "end": 3}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S12", "tokens": ["Cells", "were", "stimulated", "with", "the", "following", "combination", "of", "mAbs", "to", "T", "cell", "surface", "molecules", "(", "Meiler", "et", "al", ".", ",", "2008", ")", ":", "anti", "-", "CD2", "(", "clone", "4B2", "and", "6G4", ";", "0.5", "microg", "/", "ml", ")", ",", "anti", "-", "CD3", "(", "clone", "OKT3", ";", "0.5", "microg", "/", "ml", ")", ",", "and", "anti", "-", "CD28", "mAb", "(", "clone", "B7G5", ";", "0.5", "microg", "/", "ml", ";", "all", "from", "Sanquin", ")", "and", "cultured", "in", "serum-free", "AIM", "-", "V", "medium", "(", "Life", "Technologies", ")", "with", "the", "addition", "of", "1", "nmol", "/", "liter", "IL-2", "(", "Roche", ")", "."], "sentence": "Cells were stimulated with the following combination of mAbs to T cell surface molecules ( Meiler et al . , 2008 ) : anti - CD2 ( clone 4B2 and 6G4 ; 0.5 microg / ml ) , anti - CD3 ( clone OKT3 ; 0.5 microg / ml ) , and anti - CD28 mAb ( clone B7G5 ; 0.5 microg / ml ; all from Sanquin ) and cultured in serum-free AIM - V medium ( Life Technologies ) with the addition of 1 nmol / liter IL-2 ( Roche ) .", "event_mentions": [], "entity_mentions": [{"id": "T24", "text": "CD2", "entity_type": "Protein", "start": 25, "end": 25}, {"id": "T25", "text": "CD3", "entity_type": "Protein", "start": 40, "end": 40}, {"id": "T26", "text": "CD28", "entity_type": "Protein", "start": 54, "end": 54}, {"id": "T27", "text": "IL-2", "entity_type": "Protein", "start": 89, "end": 89}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S13", "tokens": ["TGF-beta", "(", "R", "&", "D", "Systems", ")", "was", "used", "at", "5", "ng", "/", "ml", ",", "if", "not", "stated", "otherwise", "."], "sentence": "TGF-beta ( R & D Systems ) was used at 5 ng / ml , if not stated otherwise .", "event_mentions": [], "entity_mentions": [{"id": "T28", "text": "TGF-beta", "entity_type": "Protein", "start": 0, "end": 0}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["A", "combination", "of", "PMA", "(", "25", "ng", "/", "ml", ")", "and", "ionomycin", "(", "1", "mg", "/", "ml", ";", "Sigma-Aldrich", ")", "was", "used", "."], "sentence": "A combination of PMA ( 25 ng / ml ) and ionomycin ( 1 mg / ml ; Sigma-Aldrich ) was used .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S15", "tokens": ["Human", "CD4", "+", "CD127", "-", "CD25", "high", "and", "CD4", "+", "CD127", "+", "CD25", "neg", "cells", "were", "purified", "by", "flow", "cytometry", "using", "anti", "-", "CD127", ",", "anti", "-", "CD25", "-", "PC5", "(", "Beckman", "Coulter", ")", ",", "and", "anti", "-", "CD4", "-", "FITC", "antibodies", "(", "Dako", ")", "."], "sentence": "Human CD4 + CD127 - CD25 high and CD4 + CD127 + CD25 neg cells were purified by flow cytometry using anti - CD127 , anti - CD25 - PC5 ( Beckman Coulter ) , and anti - CD4 - FITC antibodies ( Dako ) .", "event_mentions": [], "entity_mentions": [{"id": "T29", "text": "CD4", "entity_type": "Protein", "start": 1, "end": 1}, {"id": "T30", "text": "CD127", "entity_type": "Protein", "start": 3, "end": 3}, {"id": "T31", "text": "CD25", "entity_type": "Protein", "start": 5, "end": 5}, {"id": "T32", "text": "CD4", "entity_type": "Protein", "start": 8, "end": 8}, {"id": "T33", "text": "CD127", "entity_type": "Protein", "start": 10, "end": 10}, {"id": "T34", "text": "CD25", "entity_type": "Protein", "start": 12, "end": 12}, {"id": "T35", "text": "CD127", "entity_type": "Protein", "start": 23, "end": 23}, {"id": "T36", "text": "CD25", "entity_type": "Protein", "start": 27, "end": 27}, {"id": "T37", "text": "CD4", "entity_type": "Protein", "start": 38, "end": 38}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S16", "tokens": ["Mouse", "naive", "(", "CD62L", "hi", "44", "lo", "25", "-", ")", "CD4", "+", "T", "cells", "were", "purified", "by", "flow", "cytometry", "and", "activated", "in", "vitro", "with", "5", "microg", "/", "ml", "plate", "-", "bound", "anti", "-", "CD3", "and", "1", "microg", "/", "ml", "soluble", "anti", "-", "CD28", "antibodies", "(", "eBioscience", ")", "in", "RPMI", "supplemented", "with", "10", "%", "FCS", ",", "5", "mM", "beta-mercaptoethanol", ",", "and", "antibiotics", "."], "sentence": "Mouse naive ( CD62L hi 44 lo 25 - ) CD4 + T cells were purified by flow cytometry and activated in vitro with 5 microg / ml plate - bound anti - CD3 and 1 microg / ml soluble anti - CD28 antibodies ( eBioscience ) in RPMI supplemented with 10 % FCS , 5 mM beta-mercaptoethanol , and antibiotics .", "event_mentions": [], "entity_mentions": [{"id": "T38", "text": "CD62L", "entity_type": "Protein", "start": 3, "end": 3}, {"id": "T39", "text": "44", "entity_type": "Protein", "start": 5, "end": 5}, {"id": "T40", "text": "25", "entity_type": "Protein", "start": 7, "end": 7}, {"id": "T41", "text": "CD4", "entity_type": "Protein", "start": 10, "end": 10}, {"id": "T42", "text": "CD3", "entity_type": "Protein", "start": 33, "end": 33}, {"id": "T43", "text": "CD28", "entity_type": "Protein", "start": 42, "end": 42}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S17", "tokens": ["Neutralizing", "anti", "-", "IFN-gamma", "and", "anti", "-", "IL-4", "mAbs", "(", "BD", ")", "were", "used", "at", "1", "microg", "/", "ml", "concentrations", "when", "indicated", "."], "sentence": "Neutralizing anti - IFN-gamma and anti - IL-4 mAbs ( BD ) were used at 1 microg / ml concentrations when indicated .", "event_mentions": [], "entity_mentions": [{"id": "T44", "text": "IFN-gamma", "entity_type": "Protein", "start": 3, "end": 3}, {"id": "T45", "text": "IL-4", "entity_type": "Protein", "start": 7, "end": 7}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["In", "vitro", "T", "cell", "differentiation", "."], "sentence": "In vitro T cell differentiation .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S19", "tokens": ["CD4", "+", "CD45RA", "+", "magnetically", "sorted", "(", "CD45RO", "depletion", "with", "AutoMACS", ";", "Miltenyi", "Biotec", ")", "cells", "were", "stimulated", "with", "immobilized", "plate", "-", "bound", "anti", "-", "CD3", "(", "1", "microg", "/", "ml", ";", "OKT3", ";", "IgG1", ")", "and", "anti", "-", "CD28", "(", "2", "microg", "/", "ml", ")", "."], "sentence": "CD4 + CD45RA + magnetically sorted ( CD45RO depletion with AutoMACS ; Miltenyi Biotec ) cells were stimulated with immobilized plate - bound anti - CD3 ( 1 microg / ml ; OKT3 ; IgG1 ) and anti - CD28 ( 2 microg / ml ) .", "event_mentions": [{"id": "E3", "event_type": "Negative_regulation", "trigger": {"text": "depletion", "start": 8, "end": 8}, "arguments": [{"entity_id": "T48", "text": "CD45RO", "role": "Theme"}]}], "entity_mentions": [{"id": "T46", "text": "CD4", "entity_type": "Protein", "start": 0, "end": 0}, {"id": "T47", "text": "CD45RA", "entity_type": "Protein", "start": 2, "end": 2}, {"id": "T48", "text": "CD45RO", "entity_type": "Protein", "start": 7, "end": 7}, {"id": "T49", "text": "CD3", "entity_type": "Protein", "start": 25, "end": 25}, {"id": "T50", "text": "CD28", "entity_type": "Protein", "start": 39, "end": 39}, {"id": "T255", "text": "depletion", "entity_type": "Negative_regulation", "start": 8, "end": 8}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S20", "tokens": ["For", "Th1", "differentiation", "conditions", ",", "cells", "were", "stimulated", "with", "the", "following", ":", "40", "ng", "/", "ml", "IL-2", ",", "5", "microg", "/", "ml", "anti", "-", "IL-4", ",", "and", "25", "ng", "/", "ml", "IL-12", "(", "R", "&", "D", "Systems", ")", "."], "sentence": "For Th1 differentiation conditions , cells were stimulated with the following : 40 ng / ml IL-2 , 5 microg / ml anti - IL-4 , and 25 ng / ml IL-12 ( R & D Systems ) .", "event_mentions": [], "entity_mentions": [{"id": "T51", "text": "IL-2", "entity_type": "Protein", "start": 16, "end": 16}, {"id": "T52", "text": "IL-4", "entity_type": "Protein", "start": 24, "end": 24}, {"id": "T53", "text": "IL-12", "entity_type": "Protein", "start": 31, "end": 31}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S21", "tokens": ["For", "Th2", "conditions", ",", "cells", "were", "stimulated", "with", "the", "following", ":", "40", "ng", "/", "ml", "IL-2", ",", "25", "ng", "/", "ml", "IL-4", ",", "and", "5", "microg", "/", "ml", "anti", "-", "IL-12", "(", "R", "&", "D", "Systems", ")", "."], "sentence": "For Th2 conditions , cells were stimulated with the following : 40 ng / ml IL-2 , 25 ng / ml IL-4 , and 5 microg / ml anti - IL-12 ( R & D Systems ) .", "event_mentions": [], "entity_mentions": [{"id": "T54", "text": "IL-2", "entity_type": "Protein", "start": 15, "end": 15}, {"id": "T55", "text": "IL-4", "entity_type": "Protein", "start": 21, "end": 21}, {"id": "T56", "text": "IL-12", "entity_type": "Protein", "start": 30, "end": 30}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S22", "tokens": ["For", "T", "reg", "cell", "conditions", ",", "cells", "were", "stimulated", "with", "the", "following", ":", "40", "ng", "/", "ml", "IL-2", ",", "5", "ng", "/", "ml", "TGF-beta", ",", "5", "microg", "/", "ml", "anti", "-", "IL-12", ",", "5", "microg", "/", "ml", "anti", "-", "IL-4", "."], "sentence": "For T reg cell conditions , cells were stimulated with the following : 40 ng / ml IL-2 , 5 ng / ml TGF-beta , 5 microg / ml anti - IL-12 , 5 microg / ml anti - IL-4 .", "event_mentions": [], "entity_mentions": [{"id": "T57", "text": "IL-2", "entity_type": "Protein", "start": 17, "end": 17}, {"id": "T58", "text": "TGF-beta", "entity_type": "Protein", "start": 23, "end": 23}, {"id": "T59", "text": "IL-12", "entity_type": "Protein", "start": 31, "end": 31}, {"id": "T60", "text": "IL-4", "entity_type": "Protein", "start": 39, "end": 39}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S23", "tokens": ["For", "Th17", "conditions", ",", "cells", "were", "stimulated", "with", "the", "following", ":", "40", "ng", "/", "ml", "IL-2", ",", "20", "ng", "/", "ml", "IL-6", ",", "5", "ng", "/", "ml", "TGF-beta", ",", "20", "ng", "/", "ml", "IL-23", "(", "Alexis", "Biochemicals", "Corp", ".", ")", ",", "10", "ng", "/", "ml", "IL-1beta", ",", "5", "microg", "/", "ml", "anti", "-", "IL-4", ",", "and", "5", "microg", "/", "ml", "anti", "-", "IL-12", "were", "used", "."], "sentence": "For Th17 conditions , cells were stimulated with the following : 40 ng / ml IL-2 , 20 ng / ml IL-6 , 5 ng / ml TGF-beta , 20 ng / ml IL-23 ( Alexis Biochemicals Corp . ) , 10 ng / ml IL-1beta , 5 microg / ml anti - IL-4 , and 5 microg / ml anti - IL-12 were used .", "event_mentions": [], "entity_mentions": [{"id": "T61", "text": "IL-2", "entity_type": "Protein", "start": 15, "end": 15}, {"id": "T62", "text": "IL-6", "entity_type": "Protein", "start": 21, "end": 21}, {"id": "T63", "text": "TGF-beta", "entity_type": "Protein", "start": 27, "end": 27}, {"id": "T64", "text": "IL-23", "entity_type": "Protein", "start": 33, "end": 33}, {"id": "T65", "text": "IL-1beta", "entity_type": "Protein", "start": 45, "end": 45}, {"id": "T66", "text": "IL-4", "entity_type": "Protein", "start": 53, "end": 53}, {"id": "T67", "text": "IL-12", "entity_type": "Protein", "start": 62, "end": 62}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S24", "tokens": ["Proliferating", "cells", "were", "expanded", "in", "medium", "containing", "IL-2", "."], "sentence": "Proliferating cells were expanded in medium containing IL-2 .", "event_mentions": [], "entity_mentions": [{"id": "T68", "text": "IL-2", "entity_type": "Protein", "start": 7, "end": 7}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S25", "tokens": ["The", "cytokine", "profile", "of", "these", "cells", "demonstrated", "that", "IFN-gamma", "is", "the", "predominant", "cytokine", "in", "Th1", "cells", ",", "IL-4", "and", "IL-13", "in", "Th2", "cells", ",", "and", "IL-17", "in", "Th17", "cells", "(", "Akdis", "et", "al", ".", ",", "2000", ";", "Burgler", "et", "al", ".", ",", "2009", ")", "."], "sentence": "The cytokine profile of these cells demonstrated that IFN-gamma is the predominant cytokine in Th1 cells , IL-4 and IL-13 in Th2 cells , and IL-17 in Th17 cells ( Akdis et al . , 2000 ; Burgler et al . , 2009 ) .", "event_mentions": [], "entity_mentions": [{"id": "T69", "text": "IFN-gamma", "entity_type": "Protein", "start": 8, "end": 8}, {"id": "T70", "text": "IL-4", "entity_type": "Protein", "start": 17, "end": 17}, {"id": "T71", "text": "IL-13", "entity_type": "Protein", "start": 19, "end": 19}, {"id": "T72", "text": "IL-17", "entity_type": "Protein", "start": 25, "end": 25}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["Immunohistochemistry", "."], "sentence": "Immunohistochemistry .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["Human", "tonsils", "were", "obtained", "from", "tonsillectomy", "samples", "of", "hypertrophic", "and", "obstructive", "tonsils", "without", "a", "current", "infection", "."], "sentence": "Human tonsils were obtained from tonsillectomy samples of hypertrophic and obstructive tonsils without a current infection .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["Ethical", "permission", "was", "obtained", "from", "Cantonal", "Ethics", "Commission", ",", "and", "informed", "consent", "was", "obtained", "from", "patients", "."], "sentence": "Ethical permission was obtained from Cantonal Ethics Commission , and informed consent was obtained from patients .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S29", "tokens": ["Paraformaldehyde-fixed", "tonsil", "cryosections", "were", "stained", "with", "unconjugated", "rabbit", "IgG", "polyclonal", "antibody", "to", "human", "RUNX1", "(", "Santa", "Cruz", "Biotechnology", ",", "Inc", ".", ")", "or", "unconjugated", "mouse", "IgG1", "mAb", "to", "human", "RUNX3", "(", "Abcam", ")", "."], "sentence": "Paraformaldehyde-fixed tonsil cryosections were stained with unconjugated rabbit IgG polyclonal antibody to human RUNX1 ( Santa Cruz Biotechnology , Inc . ) or unconjugated mouse IgG1 mAb to human RUNX3 ( Abcam ) .", "event_mentions": [], "entity_mentions": [{"id": "T73", "text": "RUNX1", "entity_type": "Protein", "start": 13, "end": 13}, {"id": "T74", "text": "RUNX3", "entity_type": "Protein", "start": 29, "end": 29}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["After", "a", "washing", "step", ",", "the", "sections", "were", "stained", "with", "the", "corresponding", "secondary", "antibodies", "."], "sentence": "After a washing step , the sections were stained with the corresponding secondary antibodies .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S31", "tokens": ["RUNX1", "-", "binding", "antibodies", "were", "detected", "by", "using", "Alexa", "Fluor", "633-conjugated", "goat", "anti-rabbit", "IgG", "and", "RUNX3", "-", "binding", "antibodies", "were", "detected", "by", "using", "Alexa", "Fluor", "532-conjugated", "goat", "anti-mouse", "IgG1", "."], "sentence": "RUNX1 - binding antibodies were detected by using Alexa Fluor 633-conjugated goat anti-rabbit IgG and RUNX3 - binding antibodies were detected by using Alexa Fluor 532-conjugated goat anti-mouse IgG1 .", "event_mentions": [{"id": "E4", "event_type": "Binding", "trigger": {"text": "binding", "start": 2, "end": 2}, "arguments": [{"entity_id": "T75", "text": "RUNX1", "role": "Theme"}]}, {"id": "E5", "event_type": "Binding", "trigger": {"text": "binding", "start": 17, "end": 17}, "arguments": [{"entity_id": "T76", "text": "RUNX3", "role": "Theme"}]}], "entity_mentions": [{"id": "T75", "text": "RUNX1", "entity_type": "Protein", "start": 0, "end": 0}, {"id": "T76", "text": "RUNX3", "entity_type": "Protein", "start": 15, "end": 15}, {"id": "T256", "text": "binding", "entity_type": "Binding", "start": 2, "end": 2}, {"id": "T257", "text": "binding", "entity_type": "Binding", "start": 17, "end": 17}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S32", "tokens": ["Afterward", ",", "the", "sections", "were", "washed", "and", "in", "the", "case", "of", "RUNX3", "staining", "a", "blocking", "step", "with", "an", "unconjugated", "mouse", "IgG1", "mAb", "was", "used", "."], "sentence": "Afterward , the sections were washed and in the case of RUNX3 staining a blocking step with an unconjugated mouse IgG1 mAb was used .", "event_mentions": [], "entity_mentions": [{"id": "T77", "text": "RUNX3", "entity_type": "Protein", "start": 11, "end": 11}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S33", "tokens": ["Finally", ",", "the", "sections", "were", "stained", "with", "Alexa", "Fluor", "488-conjugated", "mouse", "IgG1", "mAb", "to", "human", "FOXP3", "(", "eBioscience", ")", "or", "the", "corresponding", "isotype", "control", "."], "sentence": "Finally , the sections were stained with Alexa Fluor 488-conjugated mouse IgG1 mAb to human FOXP3 ( eBioscience ) or the corresponding isotype control .", "event_mentions": [], "entity_mentions": [{"id": "T78", "text": "FOXP3", "entity_type": "Protein", "start": 15, "end": 15}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["Tissue", "sections", "were", "stained", "with", "DAPI", "for", "the", "demonstration", "of", "nuclei", "and", "mounted", "with", "Prolong", "antifade", "(", "Invitrogen", ")", "."], "sentence": "Tissue sections were stained with DAPI for the demonstration of nuclei and mounted with Prolong antifade ( Invitrogen ) .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["Images", "were", "acquired", "and", "analyzed", "using", "the", "confocal", "microscope", "DMI", "4000B", "and", "the", "TCS", "SPE", "system", "(", "both", "from", "Leica", ")", "."], "sentence": "Images were acquired and analyzed using the confocal microscope DMI 4000B and the TCS SPE system ( both from Leica ) .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["In", "vitro", "suppression", "assays", "."], "sentence": "In vitro suppression assays .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S37", "tokens": ["Mouse", "Foxp3", "+", "CD4", "+", "CD8", "-", "T", "cells", "were", "FACS", "purified", "based", "on", "GFP", "expressed", "from", "a", "Foxp3", "-", "IRES", "-", "GFP", "knock-in", "allele", "(", "Foxp3", "GFP", ")", "."], "sentence": "Mouse Foxp3 + CD4 + CD8 - T cells were FACS purified based on GFP expressed from a Foxp3 - IRES - GFP knock-in allele ( Foxp3 GFP ) .", "event_mentions": [{"id": "E6", "event_type": "Gene_expression", "trigger": {"text": "expressed", "start": 15, "end": 15}, "arguments": [{"entity_id": "T82", "text": "GFP", "role": "Theme"}]}], "entity_mentions": [{"id": "T79", "text": "Foxp3", "entity_type": "Protein", "start": 1, "end": 1}, {"id": "T80", "text": "CD4", "entity_type": "Protein", "start": 3, "end": 3}, {"id": "T81", "text": "CD8", "entity_type": "Protein", "start": 5, "end": 5}, {"id": "T82", "text": "GFP", "entity_type": "Protein", "start": 14, "end": 14}, {"id": "T83", "text": "Foxp3", "entity_type": "Protein", "start": 18, "end": 18}, {"id": "T84", "text": "GFP", "entity_type": "Protein", "start": 22, "end": 22}, {"id": "T85", "text": "Foxp3", "entity_type": "Protein", "start": 26, "end": 26}, {"id": "T86", "text": "GFP", "entity_type": "Protein", "start": 27, "end": 27}, {"id": "T258", "text": "expressed", "entity_type": "Gene_expression", "start": 15, "end": 15}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S38", "tokens": ["Naive", "(", "CD62L", "hi", "44", "lo", "25", "-", ")", "CD4", "+", "T", "cells", "(", "effectors", ")", "were", "FACS-purified", "from", "Cd45.1", "mice", ",", "then", "loaded", "with", "5", "microM", "CFSE", "(", "Invitrogen", ")", "."], "sentence": "Naive ( CD62L hi 44 lo 25 - ) CD4 + T cells ( effectors ) were FACS-purified from Cd45.1 mice , then loaded with 5 microM CFSE ( Invitrogen ) .", "event_mentions": [], "entity_mentions": [{"id": "T87", "text": "CD62L", "entity_type": "Protein", "start": 2, "end": 2}, {"id": "T88", "text": "44", "entity_type": "Protein", "start": 4, "end": 4}, {"id": "T89", "text": "25", "entity_type": "Protein", "start": 6, "end": 6}, {"id": "T90", "text": "CD4", "entity_type": "Protein", "start": 9, "end": 9}, {"id": "T91", "text": "Cd45.1", "entity_type": "Protein", "start": 19, "end": 19}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["Total", "splenocytes", "from", "C57BL", "/", "6", "mice", "inactivated", "with", "50", "microg", "/", "ml", "mitomycin", "C", "(", "Sigma-Aldrich", ")", "for", "45", "min", "were", "used", "as", "APCs", "."], "sentence": "Total splenocytes from C57BL / 6 mice inactivated with 50 microg / ml mitomycin C ( Sigma-Aldrich ) for 45 min were used as APCs .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S40", "tokens": ["A", "total", "of", "4", "x", "105", "CD4", "+", "cells", "(", "CFSE-loaded", "CD25", "-", "plus", "Foxp3-GFP", "+", ")", "was", "mixed", "with", "105", "APCs", "+", "1", "microg", "/", "ml", "anti", "-", "CD3", "mAb", "per", "well", "of", "a", "96", "well", "round", "bottom", "plate", "."], "sentence": "A total of 4 x 105 CD4 + cells ( CFSE-loaded CD25 - plus Foxp3-GFP + ) was mixed with 105 APCs + 1 microg / ml anti - CD3 mAb per well of a 96 well round bottom plate .", "event_mentions": [], "entity_mentions": [{"id": "T92", "text": "CD4", "entity_type": "Protein", "start": 6, "end": 6}, {"id": "T93", "text": "CD25", "entity_type": "Protein", "start": 11, "end": 11}, {"id": "T94", "text": "Foxp3-GFP", "entity_type": "Protein", "start": 14, "end": 14}, {"id": "T95", "text": "CD3", "entity_type": "Protein", "start": 29, "end": 29}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["Proliferation", "of", "the", "effector", "cells", "was", "analyzed", "by", "CFSE", "dilution", "."], "sentence": "Proliferation of the effector cells was analyzed by CFSE dilution .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S42", "tokens": ["Apoptosis", "of", "the", "cells", "was", "investigated", "by", "annexin", "V", "staining", "and", "flow", "cytometry", "."], "sentence": "Apoptosis of the cells was investigated by annexin V staining and flow cytometry .", "event_mentions": [], "entity_mentions": [{"id": "T96", "text": "annexin V", "entity_type": "Protein", "start": 7, "end": 8}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S43", "tokens": ["Positive", "and", "negative", "control", "gates", "were", "made", "according", "to", "T", "cells", "cultured", "only", "in", "the", "presence", "of", "IL-2", "without", "anti", "-", "CD3", "/", "28", "stimulation", "."], "sentence": "Positive and negative control gates were made according to T cells cultured only in the presence of IL-2 without anti - CD3 / 28 stimulation .", "event_mentions": [], "entity_mentions": [{"id": "T97", "text": "IL-2", "entity_type": "Protein", "start": 17, "end": 17}, {"id": "T98", "text": "CD3", "entity_type": "Protein", "start": 21, "end": 21}, {"id": "T99", "text": "28", "entity_type": "Protein", "start": 23, "end": 23}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S44", "tokens": ["Human", "naive", "CD4", "+", "T", "cells", "were", "isolated", "by", "negative", "selection", "by", "MACS", "from", "PBMCs", "and", "either", "transfected", "with", "a", "scrambled", "siRNA", "or", "with", "a", "combination", "of", "RUNX1", "and", "RUNX3", "siRNA", "."], "sentence": "Human naive CD4 + T cells were isolated by negative selection by MACS from PBMCs and either transfected with a scrambled siRNA or with a combination of RUNX1 and RUNX3 siRNA .", "event_mentions": [{"id": "E7", "event_type": "Negative_regulation", "trigger": {"text": "siRNA", "start": 30, "end": 30}, "arguments": [{"entity_id": "T101", "text": "RUNX1", "role": "Theme"}]}, {"id": "E8", "event_type": "Negative_regulation", "trigger": {"text": "siRNA", "start": 30, "end": 30}, "arguments": [{"entity_id": "T102", "text": "RUNX3", "role": "Theme"}]}], "entity_mentions": [{"id": "T100", "text": "CD4", "entity_type": "Protein", "start": 2, "end": 2}, {"id": "T101", "text": "RUNX1", "entity_type": "Protein", "start": 27, "end": 27}, {"id": "T102", "text": "RUNX3", "entity_type": "Protein", "start": 29, "end": 29}, {"id": "T259", "text": "siRNA", "entity_type": "Negative_regulation", "start": 30, "end": 30}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S45", "tokens": ["Cells", "were", "then", "cultured", "under", "iT", "reg", "cell", "differentiating", "conditions", "and", "mixed", "with", "2", "x", "105", "autologous", "irradiated", "PBMCs", "that", "were", "used", "as", "APCs", "and", "autologous", "CFSE-labeled", "CD4", "+", "T", "cells", "."], "sentence": "Cells were then cultured under iT reg cell differentiating conditions and mixed with 2 x 105 autologous irradiated PBMCs that were used as APCs and autologous CFSE-labeled CD4 + T cells .", "event_mentions": [], "entity_mentions": [{"id": "T103", "text": "CD4", "entity_type": "Protein", "start": 27, "end": 27}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["T", "reg", "cell", "to", "responder", "cell", "ratio", "was", "1", ":", "20", ",", "1", ":", "10", ",", "and", "1", ":", "5", "."], "sentence": "T reg cell to responder cell ratio was 1 : 20 , 1 : 10 , and 1 : 5 .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S47", "tokens": ["To", "check", "the", "proliferation", "of", "the", "CD4", "+", "T", "cells", "without", "suppression", ",", "no", "T", "reg", "cells", "were", "added", "in", "a", "control", "group", "."], "sentence": "To check the proliferation of the CD4 + T cells without suppression , no T reg cells were added in a control group .", "event_mentions": [], "entity_mentions": [{"id": "T104", "text": "CD4", "entity_type": "Protein", "start": 6, "end": 6}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S48", "tokens": ["Cells", "were", "stimulated", "with", "2.5", "microg", "/", "ml", "anti", "-", "CD3", "mAb", ",", "cultured", "in", "a", "96-well", "plate", "and", "the", "proliferation", "of", "the", "effector", "cells", "was", "determined", "by", "analyzing", "the", "CFSE", "dilution", "by", "flow", "cytometry", "after", "5", "d", "of", "culture", "."], "sentence": "Cells were stimulated with 2.5 microg / ml anti - CD3 mAb , cultured in a 96-well plate and the proliferation of the effector cells was determined by analyzing the CFSE dilution by flow cytometry after 5 d of culture .", "event_mentions": [], "entity_mentions": [{"id": "T105", "text": "CD3", "entity_type": "Protein", "start": 10, "end": 10}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S49", "tokens": ["Gating", "on", "the", "CD4", "+", "CFSE+", "T", "cells", "enabled", "the", "exclusion", "of", "APCs", "and", "T", "reg", "cells", "."], "sentence": "Gating on the CD4 + CFSE+ T cells enabled the exclusion of APCs and T reg cells .", "event_mentions": [], "entity_mentions": [{"id": "T106", "text": "CD4", "entity_type": "Protein", "start": 3, "end": 3}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S50", "tokens": ["Cloning", "of", "the", "FOXP3", "promoter", ",", "construction", "of", "mutant", "FOXP3", "promoter", ",", "and", "RUNX", "expression", "plasmids", "."], "sentence": "Cloning of the FOXP3 promoter , construction of mutant FOXP3 promoter , and RUNX expression plasmids .", "event_mentions": [{"id": "E9", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 14, "end": 14}, "arguments": [{"entity_id": "T109", "text": "RUNX", "role": "Theme"}]}], "entity_mentions": [{"id": "T107", "text": "FOXP3", "entity_type": "Protein", "start": 3, "end": 3}, {"id": "T108", "text": "FOXP3", "entity_type": "Protein", "start": 9, "end": 9}, {"id": "T109", "text": "RUNX", "entity_type": "Protein", "start": 13, "end": 13}, {"id": "T260", "text": "expression", "entity_type": "Gene_expression", "start": 14, "end": 14}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S51", "tokens": ["The", "FOXP3", "promoter", "was", "cloned", "into", "the", "pGL3", "basic", "vector", "(", "Promega", "Biotech", ")", "to", "generate", "pGL3", "FOXP3", "-511", "/", "+176", "(", "Mantel", "et", "al", ".", ",", "2006", ")", "."], "sentence": "The FOXP3 promoter was cloned into the pGL3 basic vector ( Promega Biotech ) to generate pGL3 FOXP3 -511 / +176 ( Mantel et al . , 2006 ) .", "event_mentions": [], "entity_mentions": [{"id": "T110", "text": "FOXP3", "entity_type": "Protein", "start": 1, "end": 1}, {"id": "T111", "text": "FOXP3", "entity_type": "Protein", "start": 17, "end": 17}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S52", "tokens": ["Site", "-", "directed", "mutagenesis", "for", "the", "three", "putative", "RUNX", "binding", "sites", "in", "the", "FOXP3", "promoter", "region", "was", "introduced", "using", "the", "QuickChange", "kit", "(", "Stratagene", ")", ",", "according", "to", "the", "manufacturer", "'s", "instructions", "and", "confirmed", "by", "sequencing", "the", "DNA", "."], "sentence": "Site - directed mutagenesis for the three putative RUNX binding sites in the FOXP3 promoter region was introduced using the QuickChange kit ( Stratagene ) , according to the manufacturer 's instructions and confirmed by sequencing the DNA .", "event_mentions": [], "entity_mentions": [{"id": "T112", "text": "FOXP3", "entity_type": "Protein", "start": 13, "end": 13}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["The", "following", "primers", "and", "their", "complementary", "strands", "were", "used", ":", "foxp", "runx-333", ",", "forward", "5'-CACTTTTGTTTTAAAAACTGTCCTTTCTCATGAGCCCTATTATC-3", "'", ";", "foxp", "runx-333", "reverse", "5'-GATAATAGGGCTCATGAGAAAGGACAGTTTTTAAAACAAAAGTG-3", "'", ";", "foxp", "runx-287", "forward", "5'-CCTCTCACCTCTGTCCTGAGGGGAAGAAATC-3", "'", ";", "foxp", "runx-287", "reverse", "5'-GATTTCTTCCCCTCAGGACAGAGGTGAGAGG-3", "'", ";", "foxp", "runx-53", "forward", "5'-GCTTCCACACCGTACAGCGTCCTTTTTCTTCTCGGTATAAAAG-3", "'", ";", "foxp", "runx-53", "reverse", "5'-CTTTTATACCGAGAAGAAAAAGGACGCTGTACGGTGTGGAAGC-3", "'", "."], "sentence": "The following primers and their complementary strands were used : foxp runx-333 , forward 5'-CACTTTTGTTTTAAAAACTGTCCTTTCTCATGAGCCCTATTATC-3 ' ; foxp runx-333 reverse 5'-GATAATAGGGCTCATGAGAAAGGACAGTTTTTAAAACAAAAGTG-3 ' ; foxp runx-287 forward 5'-CCTCTCACCTCTGTCCTGAGGGGAAGAAATC-3 ' ; foxp runx-287 reverse 5'-GATTTCTTCCCCTCAGGACAGAGGTGAGAGG-3 ' ; foxp runx-53 forward 5'-GCTTCCACACCGTACAGCGTCCTTTTTCTTCTCGGTATAAAAG-3 ' ; foxp runx-53 reverse 5'-CTTTTATACCGAGAAGAAAAAGGACGCTGTACGGTGTGGAAGC-3 ' .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S54", "tokens": ["The", "human", "RUNX1", "fragment", "from", "the", "Addgene", "plasmid", "12504", "(", "Biggs", "et", "al", ".", ",", "2006", ")", "pFlagCMV2-AML1B", "was", "sub-cloned", "in", "the", "pEGFPN1", "vector", "(", "Clontech", "Laboratories", ")", "."], "sentence": "The human RUNX1 fragment from the Addgene plasmid 12504 ( Biggs et al . , 2006 ) pFlagCMV2-AML1B was sub-cloned in the pEGFPN1 vector ( Clontech Laboratories ) .", "event_mentions": [], "entity_mentions": [{"id": "T113", "text": "RUNX1", "entity_type": "Protein", "start": 2, "end": 2}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S55", "tokens": ["The", "RUNX3", "vector", "pCMV", "human", "RUNX3", ",", "which", "was", "a", "gift", "from", "K", ".", "Ito", "(", "Institute", "of", "Molecular", "and", "Cell", "Biology", ",", "Proteos", ",", "Singapore", ")", "was", "subcloned", "into", "pEGFPN1", "vector", "(", "Clontech", "Laboratories", ";", "Yamamura", "et", "al", ".", ",", "2006", ")", "."], "sentence": "The RUNX3 vector pCMV human RUNX3 , which was a gift from K . Ito ( Institute of Molecular and Cell Biology , Proteos , Singapore ) was subcloned into pEGFPN1 vector ( Clontech Laboratories ; Yamamura et al . , 2006 ) .", "event_mentions": [], "entity_mentions": [{"id": "T114", "text": "RUNX3", "entity_type": "Protein", "start": 1, "end": 1}, {"id": "T115", "text": "RUNX3", "entity_type": "Protein", "start": 5, "end": 5}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["Transfections", "and", "reporter", "gene", "assays", "."], "sentence": "Transfections and reporter gene assays .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["T", "cells", "were", "rested", "in", "serum-free", "AIM-V", "medium", "overnight", "."], "sentence": "T cells were rested in serum-free AIM-V medium overnight .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S58", "tokens": ["3.5", "microg", "of", "the", "FOXP3", "promoter", "luciferase", "reporter", "vector", "or", "a", "combination", "together", "with", "the", "RUNX1", ",", "RUNX3", "pEGFPN1", "vector", ",", "and", "0.5", "microg", "phRL-TK", "were", "added", "to", "3", "x", "106", "CD4", "+", "T", "cells", "resuspended", "in", "100", "microl", "of", "Nucleofector", "solution", "(", "Lonza", ")", "and", "electroporated", "using", "the", "program", "U-15", "."], "sentence": "3.5 microg of the FOXP3 promoter luciferase reporter vector or a combination together with the RUNX1 , RUNX3 pEGFPN1 vector , and 0.5 microg phRL-TK were added to 3 x 106 CD4 + T cells resuspended in 100 microl of Nucleofector solution ( Lonza ) and electroporated using the program U-15 .", "event_mentions": [], "entity_mentions": [{"id": "T116", "text": "FOXP3", "entity_type": "Protein", "start": 4, "end": 4}, {"id": "T117", "text": "luciferase", "entity_type": "Protein", "start": 6, "end": 6}, {"id": "T118", "text": "RUNX1", "entity_type": "Protein", "start": 15, "end": 15}, {"id": "T119", "text": "RUNX3", "entity_type": "Protein", "start": 17, "end": 17}, {"id": "T120", "text": "CD4", "entity_type": "Protein", "start": 31, "end": 31}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S59", "tokens": ["After", "a", "24-h", "culture", "in", "serum-free", "conditions", "and", "stimuli", "as", "indicated", "in", "the", "figures", ",", "luciferase", "activity", "was", "measured", "by", "the", "dual", "luciferase", "assay", "system", "(", "Promega", ")", "according", "to", "the", "manufacturer", "'s", "instructions", "."], "sentence": "After a 24-h culture in serum-free conditions and stimuli as indicated in the figures , luciferase activity was measured by the dual luciferase assay system ( Promega ) according to the manufacturer 's instructions .", "event_mentions": [], "entity_mentions": [{"id": "T121", "text": "luciferase", "entity_type": "Protein", "start": 15, "end": 15}, {"id": "T122", "text": "luciferase", "entity_type": "Protein", "start": 22, "end": 22}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S60", "tokens": ["PMA", "/", "ionomycin", "was", "used", "to", "stimulate", "the", "cells", ",", "because", "the", "transfection", "was", "only", "transient", "and", "the", "luciferase", "assay", "required", "a", "strong", "and", "fast", "stimulation", "of", "the", "cells", "."], "sentence": "PMA / ionomycin was used to stimulate the cells , because the transfection was only transient and the luciferase assay required a strong and fast stimulation of the cells .", "event_mentions": [], "entity_mentions": [{"id": "T123", "text": "luciferase", "entity_type": "Protein", "start": 18, "end": 18}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S61", "tokens": ["To", "evaluate", "the", "effect", "of", "overexpression", "of", "RUNX1", "or", "RUNX3", "on", "FOXP3", "protein", "levels", ",", "CD4", "+", "T", "cells", "were", "preactivated", "with", "2", "microg", "/", "ml", "phytohemagglutinin", "(", "Sigma-Aldrich", ")", "in", "serum-free", "AIM-V", "medium", "in", "the", "presence", "of", "1", "nmol", "/", "liter", "IL-2", "(", "Roche", ")", "for", "12", "h", ",", "and", "then", "transfected", "with", "the", "vector", "pEGFPN1", "containing", "the", "RUNX1", "or", "RUNX3", "fragment", "using", "the", "Nucleofector", "system", "(", "Amaxa", "Biosystems", ")", "and", "the", "program", "T-23", "."], "sentence": "To evaluate the effect of overexpression of RUNX1 or RUNX3 on FOXP3 protein levels , CD4 + T cells were preactivated with 2 microg / ml phytohemagglutinin ( Sigma-Aldrich ) in serum-free AIM-V medium in the presence of 1 nmol / liter IL-2 ( Roche ) for 12 h , and then transfected with the vector pEGFPN1 containing the RUNX1 or RUNX3 fragment using the Nucleofector system ( Amaxa Biosystems ) and the program T-23 .", "event_mentions": [{"id": "E10", "event_type": "Regulation", "trigger": {"text": "effect", "start": 3, "end": 3}, "arguments": [{"entity_id": "T126", "text": "FOXP3", "role": "Theme"}, {"entity_id": "T262", "text": "overexpression", "role": "Cause"}]}, {"id": "E12", "event_type": "Regulation", "trigger": {"text": "effect", "start": 3, "end": 3}, "arguments": [{"entity_id": "T126", "text": "FOXP3", "role": "Theme"}, {"entity_id": "T262", "text": "overexpression", "role": "Cause"}]}, {"id": "E11", "event_type": "Gene_expression", "trigger": {"text": "overexpression", "start": 5, "end": 5}, "arguments": [{"entity_id": "T124", "text": "RUNX1", "role": "Theme"}]}, {"id": "E13", "event_type": "Gene_expression", "trigger": {"text": "overexpression", "start": 5, "end": 5}, "arguments": [{"entity_id": "T125", "text": "RUNX3", "role": "Theme"}]}, {"id": "E14", "event_type": "Gene_expression", "trigger": {"text": "transfected", "start": 52, "end": 52}, "arguments": [{"entity_id": "T130", "text": "RUNX1", "role": "Theme"}]}, {"id": "E15", "event_type": "Gene_expression", "trigger": {"text": "transfected", "start": 52, "end": 52}, "arguments": [{"entity_id": "T131", "text": "RUNX3", "role": "Theme"}]}], "entity_mentions": [{"id": "T124", "text": "RUNX1", "entity_type": "Protein", "start": 7, "end": 7}, {"id": "T125", "text": "RUNX3", "entity_type": "Protein", "start": 9, "end": 9}, {"id": "T126", "text": "FOXP3", "entity_type": "Protein", "start": 11, "end": 11}, {"id": "T127", "text": "CD4", "entity_type": "Protein", "start": 15, "end": 15}, {"id": "T128", "text": "phytohemagglutinin", "entity_type": "Protein", "start": 26, "end": 26}, {"id": "T129", "text": "IL-2", "entity_type": "Protein", "start": 42, "end": 42}, {"id": "T130", "text": "RUNX1", "entity_type": "Protein", "start": 59, "end": 59}, {"id": "T131", "text": "RUNX3", "entity_type": "Protein", "start": 61, "end": 61}, {"id": "T261", "text": "effect", "entity_type": "Regulation", "start": 3, "end": 3}, {"id": "T262", "text": "overexpression", "entity_type": "Gene_expression", "start": 5, "end": 5}, {"id": "T263", "text": "transfected", "entity_type": "Gene_expression", "start": 52, "end": 52}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S62", "tokens": ["FOXP3", "expression", "was", "evaluated", "by", "flow", "cytometry", "after", "48", "h", "of", "culture", "in", "AIM-V", "medium", "containing", "1", "nmol", "/", "liter", "IL-2", "."], "sentence": "FOXP3 expression was evaluated by flow cytometry after 48 h of culture in AIM-V medium containing 1 nmol / liter IL-2 .", "event_mentions": [{"id": "E16", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 1, "end": 1}, "arguments": [{"entity_id": "T132", "text": "FOXP3", "role": "Theme"}]}], "entity_mentions": [{"id": "T132", "text": "FOXP3", "entity_type": "Protein", "start": 0, "end": 0}, {"id": "T133", "text": "IL-2", "entity_type": "Protein", "start": 20, "end": 20}, {"id": "T264", "text": "expression", "entity_type": "Gene_expression", "start": 1, "end": 1}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["RNA", "interference", "."], "sentence": "RNA interference .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S64", "tokens": ["CD4", "+", "or", "naive", "CD4", "+", "T", "cells", "were", "resuspended", "in", "100", "microl", "of", "Nucleofector", "solution", "(", "Lonza", ")", "and", "electroporated", "with", "2", "microM", "siRNA", "using", "the", "Nucleofector", "technology", "program", "U-14", "(", "Lonza", ")", "."], "sentence": "CD4 + or naive CD4 + T cells were resuspended in 100 microl of Nucleofector solution ( Lonza ) and electroporated with 2 microM siRNA using the Nucleofector technology program U-14 ( Lonza ) .", "event_mentions": [], "entity_mentions": [{"id": "T134", "text": "CD4", "entity_type": "Protein", "start": 0, "end": 0}, {"id": "T135", "text": "CD4", "entity_type": "Protein", "start": 4, "end": 4}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S65", "tokens": ["Five", "different", "Silencer", "or", "Silencer", "Select", "Pre-designed", "siRNAs", "for", "RUNX1", "(", "Applied", "Biosystems", ")", "and", "three", "Silencer", "Pre-designed", "siRNAs", "for", "RUNX3", "(", "Applied", "Biosystems", ")", "were", "tested", ",", "and", "the", "best", "was", "selected", "for", "all", "further", "experiments", "."], "sentence": "Five different Silencer or Silencer Select Pre-designed siRNAs for RUNX1 ( Applied Biosystems ) and three Silencer Pre-designed siRNAs for RUNX3 ( Applied Biosystems ) were tested , and the best was selected for all further experiments .", "event_mentions": [{"id": "E17", "event_type": "Negative_regulation", "trigger": {"text": "siRNAs", "start": 7, "end": 7}, "arguments": [{"entity_id": "T136", "text": "RUNX1", "role": "Theme"}]}, {"id": "E18", "event_type": "Negative_regulation", "trigger": {"text": "siRNAs", "start": 18, "end": 18}, "arguments": [{"entity_id": "T137", "text": "RUNX3", "role": "Theme"}]}], "entity_mentions": [{"id": "T136", "text": "RUNX1", "entity_type": "Protein", "start": 9, "end": 9}, {"id": "T137", "text": "RUNX3", "entity_type": "Protein", "start": 20, "end": 20}, {"id": "T265", "text": "siRNAs", "entity_type": "Negative_regulation", "start": 7, "end": 7}, {"id": "T266", "text": "siRNAs", "entity_type": "Negative_regulation", "start": 18, "end": 18}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["The", "Silencer", "Negative", "Control", "#", "1", "siRNA", "(", "Applied", "Biosystems", ")", "was", "used", "for", "normalization", "."], "sentence": "The Silencer Negative Control # 1 siRNA ( Applied Biosystems ) was used for normalization .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S67", "tokens": ["Cells", "were", "then", "left", "unstimulated", "or", "were", "stimulated", "after", "12", "h", "with", "anti", "-", "CD2", ",", "anti", "-", "CD3", ",", "and", "anti", "-", "CD28", "."], "sentence": "Cells were then left unstimulated or were stimulated after 12 h with anti - CD2 , anti - CD3 , and anti - CD28 .", "event_mentions": [], "entity_mentions": [{"id": "T138", "text": "CD2", "entity_type": "Protein", "start": 14, "end": 14}, {"id": "T139", "text": "CD3", "entity_type": "Protein", "start": 18, "end": 18}, {"id": "T140", "text": "CD28", "entity_type": "Protein", "start": 23, "end": 23}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S68", "tokens": ["Cells", "were", "cultured", "in", "serum-free", "AIM-V", "medium", "with", "the", "addition", "of", "1", "nmol", "/", "l", "IL-2", "(", "Roche", ")", "."], "sentence": "Cells were cultured in serum-free AIM-V medium with the addition of 1 nmol / l IL-2 ( Roche ) .", "event_mentions": [], "entity_mentions": [{"id": "T141", "text": "AIM-V", "entity_type": "Protein", "start": 5, "end": 5}, {"id": "T142", "text": "IL-2", "entity_type": "Protein", "start": 15, "end": 15}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["Cells", "were", "harvested", "for", "mRNA", "detection", "of", "the", "target", "genes", "after", "24", "h", "and", "for", "protein", "detection", "after", "48", "h", "."], "sentence": "Cells were harvested for mRNA detection of the target genes after 24 h and for protein detection after 48 h .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["RNA", "isolation", "and", "cDNA", "synthesis", "."], "sentence": "RNA isolation and cDNA synthesis .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["RNA", "was", "isolated", "using", "the", "RNeasy", "Mini", "kit", "(", "QIAGEN", ")", "according", "to", "the", "manufacturer", "'s", "protocol", "."], "sentence": "RNA was isolated using the RNeasy Mini kit ( QIAGEN ) according to the manufacturer 's protocol .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["Reverse", "transcription", "of", "human", "samples", "was", "performed", "with", "reverse", "-", "transcription", "reagents", "(", "Fermentas", ")", "with", "random", "hexamers", "according", "to", "the", "manufacturer", "'s", "protocol", "."], "sentence": "Reverse transcription of human samples was performed with reverse - transcription reagents ( Fermentas ) with random hexamers according to the manufacturer 's protocol .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["Real-time", "PCR", "."], "sentence": "Real-time PCR .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S74", "tokens": ["PCR", "primers", "and", "probes", "were", "designed", "based", "on", "the", "sequences", "reported", "in", "GenBank", "with", "the", "Primer", "Express", "software", "version", "1.2", "(", "Applied", "Biosystems", ")", "as", "follows", ":", "FOXP3", "forward", "primer", ",", "5'-GAAACAGCACATTCCCAGAGTTC-3", "'", ";", "FOXP3", "reverse", "primer", ",", "5'-ATGGCCCAGCGGATGAG-3", "'", ";", "EF-1a", "forward", "primer", ",", "5'-CTGAACCATCCAGGCCAAAT-3", "'", ";", "and", "EF-1a", "reverse", "primer", ",", "5'-GCCGTGTGGCAATCCAAT-3", "'", ",", "as", "previously", "described", "(", "Mantel", "et", "al", ".", ",", "2007", ")", "."], "sentence": "PCR primers and probes were designed based on the sequences reported in GenBank with the Primer Express software version 1.2 ( Applied Biosystems ) as follows : FOXP3 forward primer , 5'-GAAACAGCACATTCCCAGAGTTC-3 ' ; FOXP3 reverse primer , 5'-ATGGCCCAGCGGATGAG-3 ' ; EF-1a forward primer , 5'-CTGAACCATCCAGGCCAAAT-3 ' ; and EF-1a reverse primer , 5'-GCCGTGTGGCAATCCAAT-3 ' , as previously described ( Mantel et al . , 2007 ) .", "event_mentions": [], "entity_mentions": [{"id": "T143", "text": "FOXP3", "entity_type": "Protein", "start": 27, "end": 27}, {"id": "T144", "text": "FOXP3", "entity_type": "Protein", "start": 34, "end": 34}, {"id": "T145", "text": "EF-1a", "entity_type": "Protein", "start": 41, "end": 41}, {"id": "T146", "text": "EF-1a", "entity_type": "Protein", "start": 49, "end": 49}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S75", "tokens": ["GATA3", "forward", "primer", ",", "5'-GCGGGCTCTATCACAAAATGA-3", "'", ";", "and", "GATA3", "reverse", "primer", "5'-GCTCTCCTGGCTGCAGACAGC-3", "'", "(", "Mantel", "et", "al", ".", ",", "2007", ")", "."], "sentence": "GATA3 forward primer , 5'-GCGGGCTCTATCACAAAATGA-3 ' ; and GATA3 reverse primer 5'-GCTCTCCTGGCTGCAGACAGC-3 ' ( Mantel et al . , 2007 ) .", "event_mentions": [], "entity_mentions": [{"id": "T147", "text": "GATA3", "entity_type": "Protein", "start": 0, "end": 0}, {"id": "T148", "text": "GATA3", "entity_type": "Protein", "start": 8, "end": 8}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S76", "tokens": ["T-bet", "forward", "primer", ",", "5'-GATGCGCCAGGAAGTTTCAT-3", "'", ";", "T-bet", "reverse", "primer", ",", "5'-GCACAATCATCTGGGTCACATT-3", "'", ";", "RORC2", "forward", "primer", ",", "5'-CAGTCATGAGAACACAAATTGAAGTG-3", "'", ";", "and", "RORC2", "reverse", "primer", "5'-CAGGTGATAACCCCGTAGTGGAT-3", "'", "."], "sentence": "T-bet forward primer , 5'-GATGCGCCAGGAAGTTTCAT-3 ' ; T-bet reverse primer , 5'-GCACAATCATCTGGGTCACATT-3 ' ; RORC2 forward primer , 5'-CAGTCATGAGAACACAAATTGAAGTG-3 ' ; and RORC2 reverse primer 5'-CAGGTGATAACCCCGTAGTGGAT-3 ' .", "event_mentions": [], "entity_mentions": [{"id": "T149", "text": "T-bet", "entity_type": "Protein", "start": 0, "end": 0}, {"id": "T150", "text": "T-bet", "entity_type": "Protein", "start": 7, "end": 7}, {"id": "T151", "text": "RORC2", "entity_type": "Protein", "start": 14, "end": 14}, {"id": "T152", "text": "RORC2", "entity_type": "Protein", "start": 22, "end": 22}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["The", "prepared", "cDNAs", "were", "amplified", "using", "SYBR", "green", "PCR", "master", "mix", "(", "Fermentas", ")", "according", "to", "the", "recommendations", "of", "the", "manufacturer", "in", "an", "ABI", "PRISM", "7000", "Sequence", "Detection", "System", "(", "Applied", "Biosystems", ")", "."], "sentence": "The prepared cDNAs were amplified using SYBR green PCR master mix ( Fermentas ) according to the recommendations of the manufacturer in an ABI PRISM 7000 Sequence Detection System ( Applied Biosystems ) .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S78", "tokens": ["RUNX1", "and", "RUNX3", "mRNA", "was", "detected", "by", "using", "TaqMan", "Gene", "Expression", "Assays", "from", "Applied", "Biosystems", "and", "used", "according", "to", "the", "manufacturer", "'s", "instruction", "using", "TaqMan", "master", "mix", "using", "a", "7000", "real-time", "PCR", "system", "(", "Applied", "Biosystems", ")", "."], "sentence": "RUNX1 and RUNX3 mRNA was detected by using TaqMan Gene Expression Assays from Applied Biosystems and used according to the manufacturer 's instruction using TaqMan master mix using a 7000 real-time PCR system ( Applied Biosystems ) .", "event_mentions": [{"id": "E19", "event_type": "Transcription", "trigger": {"text": "mRNA", "start": 3, "end": 3}, "arguments": [{"entity_id": "T153", "text": "RUNX1", "role": "Theme"}]}, {"id": "E20", "event_type": "Transcription", "trigger": {"text": "mRNA", "start": 3, "end": 3}, "arguments": [{"entity_id": "T154", "text": "RUNX3", "role": "Theme"}]}], "entity_mentions": [{"id": "T153", "text": "RUNX1", "entity_type": "Protein", "start": 0, "end": 0}, {"id": "T154", "text": "RUNX3", "entity_type": "Protein", "start": 2, "end": 2}, {"id": "T267", "text": "mRNA", "entity_type": "Transcription", "start": 3, "end": 3}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S79", "tokens": ["PCR", "amplification", "of", "the", "housekeeping", "gene", "encoding", "elongation", "factor", "(EF)-1alpha", "or", "by", "using", "the", "18S", "rRNA", "Gene", "Expression", "Assay", "(", "Applied", "Biosystems", ")", "was", "performed", "to", "allow", "normalization", "between", "samples", "."], "sentence": "PCR amplification of the housekeeping gene encoding elongation factor (EF)-1alpha or by using the 18S rRNA Gene Expression Assay ( Applied Biosystems ) was performed to allow normalization between samples .", "event_mentions": [], "entity_mentions": [{"id": "T155", "text": "elongation factor (EF)-1alpha", "entity_type": "Protein", "start": 7, "end": 9}, {"id": "T156", "text": "18S rRNA", "entity_type": "Protein", "start": 14, "end": 15}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["Relative", "quantification", "and", "calculation", "of", "the", "range", "of", "confidence", "was", "performed", "using", "the", "comparative", "DeltaDeltaCT", "method", "(", "Applied", "Biosystems", ")", "."], "sentence": "Relative quantification and calculation of the range of confidence was performed using the comparative DeltaDeltaCT method ( Applied Biosystems ) .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S81", "tokens": ["The", "percentage", "of", "FOXP3", "mRNA", "in", "siRNA", "-", "mediated", "RUNX", "knockdown", "cells", "was", "calculated", "in", "relation", "to", "cells", ",", "which", "were", "transfected", "with", "scrambled", "control", "siRNA", "."], "sentence": "The percentage of FOXP3 mRNA in siRNA - mediated RUNX knockdown cells was calculated in relation to cells , which were transfected with scrambled control siRNA .", "event_mentions": [{"id": "E21", "event_type": "Transcription", "trigger": {"text": "mRNA", "start": 4, "end": 4}, "arguments": [{"entity_id": "T157", "text": "FOXP3", "role": "Theme"}]}, {"id": "E22", "event_type": "Positive_regulation", "trigger": {"text": "mediated", "start": 8, "end": 8}, "arguments": [{"entity_id": "T270", "text": "knockdown", "role": "Theme"}]}, {"id": "E23", "event_type": "Negative_regulation", "trigger": {"text": "knockdown", "start": 10, "end": 10}, "arguments": [{"entity_id": "T158", "text": "RUNX", "role": "Theme"}]}], "entity_mentions": [{"id": "T157", "text": "FOXP3", "entity_type": "Protein", "start": 3, "end": 3}, {"id": "T158", "text": "RUNX", "entity_type": "Protein", "start": 9, "end": 9}, {"id": "T268", "text": "mRNA", "entity_type": "Transcription", "start": 4, "end": 4}, {"id": "T269", "text": "mediated", "entity_type": "Positive_regulation", "start": 8, "end": 8}, {"id": "T270", "text": "knockdown", "entity_type": "Negative_regulation", "start": 10, "end": 10}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["Arbitrary", "units", "show", "the", "2", "-", "(", "Deltact", ")", "values", "multiplied", "by", "10", ",", "000", "incorporating", "the", "ct", "values", "of", "the", "gene", "of", "interest", "and", "the", "housekeeping", "gene", "."], "sentence": "Arbitrary units show the 2 - ( Deltact ) values multiplied by 10 , 000 incorporating the ct values of the gene of interest and the housekeeping gene .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["Flow", "cytometry", "."], "sentence": "Flow cytometry .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S84", "tokens": ["For", "analysis", "of", "human", "FOXP3", "expression", "on", "the", "single-cell", "level", ",", "cells", "were", "first", "stained", "with", "the", "monoclonal", "CD4", "mAb", "(", "Beckman", "Coulter", ")", ",", "and", "after", "fixation", "and", "permeabilization", ",", "they", "were", "incubated", "with", "anti-human", "Foxp3", "-", "Alexa", "Fluor", "488", "antibody", "(", "BioLegend", ")", "based", "on", "the", "manufacturer", "'s", "recommendations", "and", "subjected", "to", "FACS", "(", "EPICS", "XL-MCL", ";", "Beckman", "Coulter", ")", "."], "sentence": "For analysis of human FOXP3 expression on the single-cell level , cells were first stained with the monoclonal CD4 mAb ( Beckman Coulter ) , and after fixation and permeabilization , they were incubated with anti-human Foxp3 - Alexa Fluor 488 antibody ( BioLegend ) based on the manufacturer 's recommendations and subjected to FACS ( EPICS XL-MCL ; Beckman Coulter ) .", "event_mentions": [{"id": "E24", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 5, "end": 5}, "arguments": [{"entity_id": "T159", "text": "FOXP3", "role": "Theme"}]}], "entity_mentions": [{"id": "T159", "text": "FOXP3", "entity_type": "Protein", "start": 4, "end": 4}, {"id": "T160", "text": "CD4", "entity_type": "Protein", "start": 18, "end": 18}, {"id": "T161", "text": "Foxp3", "entity_type": "Protein", "start": 36, "end": 36}, {"id": "T271", "text": "expression", "entity_type": "Gene_expression", "start": 5, "end": 5}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["A", "mouse", "IgG1", "antibody", "(", "BioLegend", ")", "was", "used", "as", "an", "isotype", "control", "."], "sentence": "A mouse IgG1 antibody ( BioLegend ) was used as an isotype control .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["Data", "were", "analyzed", "with", "the", "CXP", "software", "(", "Beckman", "Coulter", ")", "."], "sentence": "Data were analyzed with the CXP software ( Beckman Coulter ) .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S87", "tokens": ["Cells", "were", "cultured", "with", "IL-2", ",", "and", "then", "left", "unstimulated", "or", "stimulated", "with", "anti", "-", "CD2", "/", "-", "CD3", "/", "-", "CD28", "mAb", "."], "sentence": "Cells were cultured with IL-2 , and then left unstimulated or stimulated with anti - CD2 / - CD3 / - CD28 mAb .", "event_mentions": [], "entity_mentions": [{"id": "T162", "text": "IL-2", "entity_type": "Protein", "start": 4, "end": 4}, {"id": "T163", "text": "CD2", "entity_type": "Protein", "start": 15, "end": 15}, {"id": "T164", "text": "CD3", "entity_type": "Protein", "start": 18, "end": 18}, {"id": "T165", "text": "CD28", "entity_type": "Protein", "start": 21, "end": 21}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["Flow", "cytometry", "analyses", "of", "the", "mouse", "cells", "were", "performed", "on", "an", "LSRII", "(", "BD", ")", "and", "cell", "sorting", "was", "performed", "on", "a", "FACSAria", "(", "BD", ")", "."], "sentence": "Flow cytometry analyses of the mouse cells were performed on an LSRII ( BD ) and cell sorting was performed on a FACSAria ( BD ) .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["All", "antibodies", "for", "these", "experiments", "were", "purchased", "from", "eBioscience", "or", "BD", "."], "sentence": "All antibodies for these experiments were purchased from eBioscience or BD .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["Western", "blotting", "."], "sentence": "Western blotting .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S91", "tokens": ["For", "human", "RUNX1", "and", "RUNX3", "analysis", "on", "the", "protein", "level", ",", "106", "cells", "were", "lysed", "and", "loaded", "next", "to", "a", "protein", "-", "mass", "ladder", "(", "Invitrogen", ")", "on", "a", "NuPAGE", "4-12", "%", "Bis-Tris", "gel", "(", "Invitrogen", ")", "."], "sentence": "For human RUNX1 and RUNX3 analysis on the protein level , 106 cells were lysed and loaded next to a protein - mass ladder ( Invitrogen ) on a NuPAGE 4-12 % Bis-Tris gel ( Invitrogen ) .", "event_mentions": [{"id": "E25", "event_type": "Gene_expression", "trigger": {"text": "protein level", "start": 8, "end": 9}, "arguments": [{"entity_id": "T166", "text": "RUNX1", "role": "Theme"}]}, {"id": "E26", "event_type": "Gene_expression", "trigger": {"text": "protein level", "start": 8, "end": 9}, "arguments": [{"entity_id": "T167", "text": "RUNX3", "role": "Theme"}]}], "entity_mentions": [{"id": "T166", "text": "RUNX1", "entity_type": "Protein", "start": 2, "end": 2}, {"id": "T167", "text": "RUNX3", "entity_type": "Protein", "start": 4, "end": 4}, {"id": "T272", "text": "protein level", "entity_type": "Gene_expression", "start": 8, "end": 9}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["The", "proteins", "were", "electroblotted", "onto", "a", "PVDF", "membrane", "(", "GE", "Healthcare", ")", "."], "sentence": "The proteins were electroblotted onto a PVDF membrane ( GE Healthcare ) .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S93", "tokens": ["Unspecific", "binding", "was", "blocked", "with", "3", "%", "milk", "in", "TBS", "Tween", ",", "and", "the", "membranes", "were", "subsequently", "incubated", "with", "a", "1", ":", "1", ",", "000", "dilution", "of", "rabbit", "anti", "-", "RUNX1", "(", "ab11903", ";", "Abcam", ")", "or", "1", ":", "200", "dilution", "of", "rabbit", "anti", "-", "RUNX3", "(", "H-50", ";", "Santa", "Cruz", "Biotechnology", ",", "Inc", ".", ")", "in", "blocking", "buffer", "containing", "3", "%", "milk", "in", "TBS", "Tween", "overnight", "at", "4degreesC", "."], "sentence": "Unspecific binding was blocked with 3 % milk in TBS Tween , and the membranes were subsequently incubated with a 1 : 1 , 000 dilution of rabbit anti - RUNX1 ( ab11903 ; Abcam ) or 1 : 200 dilution of rabbit anti - RUNX3 ( H-50 ; Santa Cruz Biotechnology , Inc . ) in blocking buffer containing 3 % milk in TBS Tween overnight at 4degreesC .", "event_mentions": [], "entity_mentions": [{"id": "T168", "text": "RUNX1", "entity_type": "Protein", "start": 30, "end": 30}, {"id": "T169", "text": "RUNX3", "entity_type": "Protein", "start": 45, "end": 45}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["The", "blots", "were", "developed", "using", "an", "anti-rabbit", "IgG", "HRP-labeled", "mAb", "(", "Cell", "Signaling", "Technology", ")", "and", "visualized", "with", "a", "LAS-1000", "gel", "documentation", "system", "(", "Fujifilm", ")", "."], "sentence": "The blots were developed using an anti-rabbit IgG HRP-labeled mAb ( Cell Signaling Technology ) and visualized with a LAS-1000 gel documentation system ( Fujifilm ) .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S95", "tokens": ["To", "confirm", "sample", "loading", "and", "transfer", "membranes", "were", "incubated", "in", "stripping", "buffer", "and", "reblocked", "for", "1", "h", "and", "reprobed", "using", "anti", "-", "GAPDH", "(", "6C5", ";", "Ambion", ")", "and", "developed", "using", "an", "anti-mouse", "IgG", "HRP-labeled", "mAb", "(", "Cell", "Signaling", "Technology", ")", "."], "sentence": "To confirm sample loading and transfer membranes were incubated in stripping buffer and reblocked for 1 h and reprobed using anti - GAPDH ( 6C5 ; Ambion ) and developed using an anti-mouse IgG HRP-labeled mAb ( Cell Signaling Technology ) .", "event_mentions": [], "entity_mentions": [{"id": "T170", "text": "GAPDH", "entity_type": "Protein", "start": 22, "end": 22}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["Pull-down", "assay", "."], "sentence": "Pull-down assay .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S97", "tokens": ["HEK293T", "cells", "were", "transfected", "with", "RUNX1", "or", "RUNX3", "using", "the", "Lipofectamine", "2000", "reagent", "(", "Invitrogen", ")", "according", "to", "the", "manufacturer", "'s", "instruction", "."], "sentence": "HEK293T cells were transfected with RUNX1 or RUNX3 using the Lipofectamine 2000 reagent ( Invitrogen ) according to the manufacturer 's instruction .", "event_mentions": [{"id": "E27", "event_type": "Gene_expression", "trigger": {"text": "transfected", "start": 3, "end": 3}, "arguments": [{"entity_id": "T171", "text": "RUNX1", "role": "Theme"}]}, {"id": "E28", "event_type": "Gene_expression", "trigger": {"text": "transfected", "start": 3, "end": 3}, "arguments": [{"entity_id": "T172", "text": "RUNX3", "role": "Theme"}]}], "entity_mentions": [{"id": "T171", "text": "RUNX1", "entity_type": "Protein", "start": 5, "end": 5}, {"id": "T172", "text": "RUNX3", "entity_type": "Protein", "start": 7, "end": 7}, {"id": "T273", "text": "transfected", "entity_type": "Gene_expression", "start": 3, "end": 3}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["Cells", "were", "lysed", "by", "sonication", "in", "HKMG", "buffer", "(", "10", "mM", "Hepes", ",", "pH", "7.9", ",", "100", "mM", "KCl", ",", "5", "mM", "MgCl2", ",", "10", "%", "glycerol", ",", "1", "mM", "DTT", ",", "0.5", "%", "Nonidet", "P-40", ")", "containing", "a", "protease", "inhibitor", "cocktail", "(", "Roche", "Diagnostics", ")", "."], "sentence": "Cells were lysed by sonication in HKMG buffer ( 10 mM Hepes , pH 7.9 , 100 mM KCl , 5 mM MgCl2 , 10 % glycerol , 1 mM DTT , 0.5 % Nonidet P-40 ) containing a protease inhibitor cocktail ( Roche Diagnostics ) .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["The", "cell", "lysate", "was", "precleared", "using", "streptavidin-agarose", "beads", "(", "GE", "Healthcare", ")", ",", "incubated", "with", "biotinylated", "double-stranded", "oligonucleotides", "containing", "the", "wild-type", "or", "mutated", "RUNX", "binding", "sites", ",", "and", "polydeoxyinosinicdeoxycytidylic", "acid", "(", "Sigma-Aldrich", ")", "."], "sentence": "The cell lysate was precleared using streptavidin-agarose beads ( GE Healthcare ) , incubated with biotinylated double-stranded oligonucleotides containing the wild-type or mutated RUNX binding sites , and polydeoxyinosinicdeoxycytidylic acid ( Sigma-Aldrich ) .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["A", "combination", "of", "all", "three", "oligonucleotides", "containing", "the", "mutated", "or", "the", "wild-type", "binding", "sites", "was", "used", "in", "the", "assay", "."], "sentence": "A combination of all three oligonucleotides containing the mutated or the wild-type binding sites was used in the assay .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["DNA", "-", "bound", "proteins", "were", "collected", "with", "streptavidin-agarose", "beads", ",", "washed", "with", "HKMG", "buffer", ",", "and", "finally", "resuspended", "in", "NuPAGE", "loading", "buffer", "(", "Invitrogen", "Life", "Technologies", ")", ",", "heated", "to", "70degreesC", "for", "10", "min", ",", "and", "separated", "on", "a", "NuPAGE", "4-12", "%", "Bis-Tris", "gel", "(", "Invitrogen", "Life", "Technologies", ")", "."], "sentence": "DNA - bound proteins were collected with streptavidin-agarose beads , washed with HKMG buffer , and finally resuspended in NuPAGE loading buffer ( Invitrogen Life Technologies ) , heated to 70degreesC for 10 min , and separated on a NuPAGE 4-12 % Bis-Tris gel ( Invitrogen Life Technologies ) .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S102", "tokens": ["The", "proteins", "were", "electroblotted", "onto", "a", "PVDF", "membrane", "(", "GE", "Healthcare", ")", "and", "detected", "using", "RUNX1", "or", "RUNX3", "antibodies", "described", "in", "the", "previous", "section", "."], "sentence": "The proteins were electroblotted onto a PVDF membrane ( GE Healthcare ) and detected using RUNX1 or RUNX3 antibodies described in the previous section .", "event_mentions": [], "entity_mentions": [{"id": "T173", "text": "RUNX1", "entity_type": "Protein", "start": 15, "end": 15}, {"id": "T174", "text": "RUNX3", "entity_type": "Protein", "start": 17, "end": 17}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["Promoter", "enzyme", "immuno", "assay", "."], "sentence": "Promoter enzyme immuno assay .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S104", "tokens": ["As", "performed", "in", "the", "pull-down", "assay", ",", "HEK293T", "cells", "were", "transfected", "with", "RUNX1", "or", "RUNX3", "and", "subsequently", "lysed", "."], "sentence": "As performed in the pull-down assay , HEK293T cells were transfected with RUNX1 or RUNX3 and subsequently lysed .", "event_mentions": [{"id": "E29", "event_type": "Gene_expression", "trigger": {"text": "transfected", "start": 10, "end": 10}, "arguments": [{"entity_id": "T176", "text": "RUNX1", "role": "Theme"}]}, {"id": "E30", "event_type": "Gene_expression", "trigger": {"text": "transfected", "start": 10, "end": 10}, "arguments": [{"entity_id": "T177", "text": "RUNX3", "role": "Theme"}]}], "entity_mentions": [{"id": "T175", "text": "HEK293T cells", "entity_type": "Protein", "start": 7, "end": 8}, {"id": "T176", "text": "RUNX1", "entity_type": "Protein", "start": 12, "end": 12}, {"id": "T177", "text": "RUNX3", "entity_type": "Protein", "start": 14, "end": 14}, {"id": "T274", "text": "transfected", "entity_type": "Gene_expression", "start": 10, "end": 10}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["Insoluble", "material", "was", "removed", "by", "centrifugation", "."], "sentence": "Insoluble material was removed by centrifugation .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["384-well", "plates", ",", "precoated", "with", "streptavidin", "(", "Thermo", "Fisher", "Scientific", ")", "were", "washed", "3", "times", "with", "washing", "buffer", "(", "PBS", "and", "0.05", "%", "Tween", "20", ")", "."], "sentence": "384-well plates , precoated with streptavidin ( Thermo Fisher Scientific ) were washed 3 times with washing buffer ( PBS and 0.05 % Tween 20 ) .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S107", "tokens": ["Biotinylated", "FOXP3", "promoter", "/", "oligonucleotides", "probes", "containing", "the", "RUNX", "binding", "sites", "were", "added", "(", "1", "pmol", "per", "well", ";", "50", "fmol", "/", "microl", ")", "and", "incubated", "for", "1", "h", "at", "room", "temperature", "."], "sentence": "Biotinylated FOXP3 promoter / oligonucleotides probes containing the RUNX binding sites were added ( 1 pmol per well ; 50 fmol / microl ) and incubated for 1 h at room temperature .", "event_mentions": [], "entity_mentions": [{"id": "T178", "text": "FOXP3", "entity_type": "Protein", "start": 1, "end": 1}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["Either", "a", "combination", "of", "all", "three", "oligonucleotides", "containing", "the", "mutated", "or", "the", "wild-type", "binding", "sites", "was", "used", "or", "single", "oligonucleotides", "were", "used", "in", "the", "assay", "."], "sentence": "Either a combination of all three oligonucleotides containing the mutated or the wild-type binding sites was used or single oligonucleotides were used in the assay .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["After", "3", "washing", "steps", "with", "washing", "buffer", ",", "the", "nuclear", "extract", "was", "added", "(", "concentration", ">", "0.2", "microg", "/", "microl", ")", "and", "incubated", "overnight", "at", "4degreesC", "."], "sentence": "After 3 washing steps with washing buffer , the nuclear extract was added ( concentration > 0.2 microg / microl ) and incubated overnight at 4degreesC .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["The", "lysates", "were", "incubated", "with", "10", "microg", "of", "poly-deoxyinosinic-deoxycytidylic", "acid", "(", "Sigma-Aldrich", ")", "."], "sentence": "The lysates were incubated with 10 microg of poly-deoxyinosinic-deoxycytidylic acid ( Sigma-Aldrich ) .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S111", "tokens": ["The", "plate", "was", "washed", "with", "HKMG", "buffer", "and", "incubated", "with", "a", "1", ":", "1000", "dilution", "of", "rabbit", "anti", "-", "RUNX1", "(", "ab11903", ",", "Abcam", ")", "or", "1", ":", "200", "dilution", "of", "rabbit", "anti", "-", "RUNX3", "(", "H-50", ",", "Santa", "Cruz", "Biotechnology", ",", "Inc", ".", ")", "at", "4degreesC", "for", "2", "h", "."], "sentence": "The plate was washed with HKMG buffer and incubated with a 1 : 1000 dilution of rabbit anti - RUNX1 ( ab11903 , Abcam ) or 1 : 200 dilution of rabbit anti - RUNX3 ( H-50 , Santa Cruz Biotechnology , Inc . ) at 4degreesC for 2 h .", "event_mentions": [], "entity_mentions": [{"id": "T179", "text": "RUNX1", "entity_type": "Protein", "start": 19, "end": 19}, {"id": "T180", "text": "RUNX3", "entity_type": "Protein", "start": 34, "end": 34}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["After", "three", "washing", "steps", "with", "HKMG", "buffer", ",", "a", "secondary", "antibody", "(", "anti-rabbit", "IgG-HRP", ",", "1", ":", "3", ",", "000", "in", "HKMG", "buffer", ",", "Cell", "Signaling", "Technology", ")", "was", "added", ",", "and", "the", "plate", "was", "incubated", "for", "1", "h", "at", "4degreesC", "."], "sentence": "After three washing steps with HKMG buffer , a secondary antibody ( anti-rabbit IgG-HRP , 1 : 3 , 000 in HKMG buffer , Cell Signaling Technology ) was added , and the plate was incubated for 1 h at 4degreesC .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["The", "wells", "were", "washed", "4", "times", "with", "HKMG", "buffer", "before", "adding", "the", "substrate", "reagent", "(", "R", "&", "D", "Systems", ")", "."], "sentence": "The wells were washed 4 times with HKMG buffer before adding the substrate reagent ( R & D Systems ) .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["The", "colorimetric", "reaction", "was", "stopped", "by", "adding", "2", "M", "H2SO4", "."], "sentence": "The colorimetric reaction was stopped by adding 2 M H2SO4 .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["Absorbance", "at", "450", "nm", "was", "measured", "using", "a", "microplate", "reader", "(", "Berthold", "Technologies", ")", "."], "sentence": "Absorbance at 450 nm was measured using a microplate reader ( Berthold Technologies ) .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["ChIP", "."], "sentence": "ChIP .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S117", "tokens": ["Human", "naive", "CD4", "+", "T", "cells", "were", "cultured", "either", "with", "IL-2", "only", "or", "with", "IL-2", ",", "anti", "-", "CD2", "/", "3", "/", "28", ",", "and", "TGF-beta", "for", "72", "h", ",", "and", "protein", "-", "DNA", "complexes", "were", "fixed", "by", "cross-linking", "with", "formaldehyde", "in", "a", "final", "concentration", "of", "1.42", "%", "for", "15", "min", "."], "sentence": "Human naive CD4 + T cells were cultured either with IL-2 only or with IL-2 , anti - CD2 / 3 / 28 , and TGF-beta for 72 h , and protein - DNA complexes were fixed by cross-linking with formaldehyde in a final concentration of 1.42 % for 15 min .", "event_mentions": [], "entity_mentions": [{"id": "T181", "text": "CD4", "entity_type": "Protein", "start": 2, "end": 2}, {"id": "T182", "text": "IL-2", "entity_type": "Protein", "start": 10, "end": 10}, {"id": "T183", "text": "IL-2", "entity_type": "Protein", "start": 14, "end": 14}, {"id": "T184", "text": "CD2", "entity_type": "Protein", "start": 18, "end": 18}, {"id": "T185", "text": "3", "entity_type": "Protein", "start": 20, "end": 20}, {"id": "T186", "text": "28", "entity_type": "Protein", "start": 22, "end": 22}, {"id": "T187", "text": "TGF-beta", "entity_type": "Protein", "start": 25, "end": 25}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["Formaldehyde", "was", "quenched", "with", "125", "mM", "glycine", "for", "5", "min", ",", "and", "cells", "were", "subsequently", "harvested", "."], "sentence": "Formaldehyde was quenched with 125 mM glycine for 5 min , and cells were subsequently harvested .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["The", "ChIP", "assay", "was", "performed", "as", "described", "in", "the", "fast", "chromatin", "immunoprecipitation", "method", "(", "Nelson", "et", "al", ".", ",", "2006", ")", "."], "sentence": "The ChIP assay was performed as described in the fast chromatin immunoprecipitation method ( Nelson et al . , 2006 ) .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S120", "tokens": ["Cells", "were", "lysed", "with", "immunoprecipitation", "buffer", "(", "150", "mM", "NaCl", ",", "50", "mM", "Tris-HCl", ",", "pH", "7.5", ",", "5", "mM", "EDTA", ",", "NP-40", "[", "0.5", "%", "vol", "/", "vol", "]", ")", "containing", "phosphatase", "(", "Roche", ")", "and", "protease", "inhibitors", "cocktails", "(", "Roche", ")", ",", "the", "nuclear", "pellet", "was", "washed", ",", "the", "chromatin", "was", "sheared", "by", "sonication", "and", "incubated", "with", "antibodies", "for", "RUNX1", "(", "H-65", "X", ";", "Santa", "Cruz", "Biotechnology", ",", "Inc", ".", ")", ",", "RUNX3", "(", "H-50", "X", ";", "Santa", "Cruz", "Biotechnology", ",", "Inc", ".", ")", ",", "CBFbeta", "(", "PEBP2beta", ";", "FL-182", "X", ";", "Santa", "Cruz", "Biotechnology", ",", "Inc", ".", ")", ",", "and", "as", "controls", "normal", "rabbit", "IgG", "(", "Santa", "Cruz", "Biotechnology", ",", "Inc", ".", ")", ",", "anti-human", "RNA", "polymerase", "II", "antibody", ",", "and", "mouse", "control", "IgG", "(", "both", "from", "SA", "Biosciences", ")", "."], "sentence": "Cells were lysed with immunoprecipitation buffer ( 150 mM NaCl , 50 mM Tris-HCl , pH 7.5 , 5 mM EDTA , NP-40 [ 0.5 % vol / vol ] ) containing phosphatase ( Roche ) and protease inhibitors cocktails ( Roche ) , the nuclear pellet was washed , the chromatin was sheared by sonication and incubated with antibodies for RUNX1 ( H-65 X ; Santa Cruz Biotechnology , Inc . ) , RUNX3 ( H-50 X ; Santa Cruz Biotechnology , Inc . ) , CBFbeta ( PEBP2beta ; FL-182 X ; Santa Cruz Biotechnology , Inc . ) , and as controls normal rabbit IgG ( Santa Cruz Biotechnology , Inc . ) , anti-human RNA polymerase II antibody , and mouse control IgG ( both from SA Biosciences ) .", "event_mentions": [], "entity_mentions": [{"id": "T188", "text": "RUNX1", "entity_type": "Protein", "start": 61, "end": 61}, {"id": "T189", "text": "RUNX3", "entity_type": "Protein", "start": 74, "end": 74}, {"id": "T190", "text": "CBFbeta", "entity_type": "Protein", "start": 87, "end": 87}, {"id": "T191", "text": "RNA polymerase II", "entity_type": "Protein", "start": 118, "end": 120}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S121", "tokens": ["The", "cleared", "chromatin", "was", "incubated", "with", "protein", "A", "agarose", "beads", "and", ",", "after", "several", "washing", "steps", ",", "DNA", "was", "isolated", "with", "10", "%", "(", "wt", "/", "vol", ")", "Chelex", "100", "resin", "."], "sentence": "The cleared chromatin was incubated with protein A agarose beads and , after several washing steps , DNA was isolated with 10 % ( wt / vol ) Chelex 100 resin .", "event_mentions": [], "entity_mentions": [{"id": "T192", "text": "protein A", "entity_type": "Protein", "start": 6, "end": 7}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S122", "tokens": ["Samples", "were", "treated", "with", "proteinase", "K", "at", "55degreesC", "for", "30", "min", "."], "sentence": "Samples were treated with proteinase K at 55degreesC for 30 min .", "event_mentions": [], "entity_mentions": [{"id": "T193", "text": "proteinase K", "entity_type": "Protein", "start": 4, "end": 5}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S123", "tokens": ["The", "proteinase", "K", "was", "then", "inactivated", "by", "boiling", "the", "samples", "for", "10", "min", "."], "sentence": "The proteinase K was then inactivated by boiling the samples for 10 min .", "event_mentions": [], "entity_mentions": [{"id": "T194", "text": "proteinase K", "entity_type": "Protein", "start": 1, "end": 2}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["The", "purified", "DNA", "was", "used", "in", "a", "real-time", "PCR", "reaction", "."], "sentence": "The purified DNA was used in a real-time PCR reaction .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S125", "tokens": ["Specific", "primers", "for", "the", "FOXP3", "promoter", ",", "spanning", "the", "region", "from", "-87", "to", "-3", ",", "FOXP3", "promoter", "forward", "primer", "5'-AGAGGTCTGCGGCTTCCA-3", "'", ",", "FOXP3", "promoter", "reverse", "primer", "5'-GGAAACTGTCACGTATCAAAAACAA-3", "'", ",", "or", "control", "GAPDH", "primer", "(", "SA", "Biosciences", ")", "for", "the", "RNA", "polymerase", "II", "were", "used", "."], "sentence": "Specific primers for the FOXP3 promoter , spanning the region from -87 to -3 , FOXP3 promoter forward primer 5'-AGAGGTCTGCGGCTTCCA-3 ' , FOXP3 promoter reverse primer 5'-GGAAACTGTCACGTATCAAAAACAA-3 ' , or control GAPDH primer ( SA Biosciences ) for the RNA polymerase II were used .", "event_mentions": [], "entity_mentions": [{"id": "T195", "text": "FOXP3", "entity_type": "Protein", "start": 4, "end": 4}, {"id": "T196", "text": "FOXP3", "entity_type": "Protein", "start": 15, "end": 15}, {"id": "T197", "text": "FOXP3", "entity_type": "Protein", "start": 22, "end": 22}, {"id": "T198", "text": "GAPDH", "entity_type": "Protein", "start": 31, "end": 31}, {"id": "T199", "text": "RNA polymerase II", "entity_type": "Protein", "start": 39, "end": 41}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["A", "negative", "control", "PCR", "for", "each", "immunoprecipitation", "using", "IGX1A", "negative", "control", "primer", "targeting", "ORF-free", "intergenic", "DNA", "(", "SA", "Biosciences", ")", "was", "used", "."], "sentence": "A negative control PCR for each immunoprecipitation using IGX1A negative control primer targeting ORF-free intergenic DNA ( SA Biosciences ) was used .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["The", "fold", "enrichment", "in", "site", "occupancy", "was", "calculated", "incorporating", "IgG", "control", "values", "and", "input", "DNA", "values", "using", "the", "ChampionChIP", "qPCR", "data", "analysis", "file", "(", "SA", "Biosciences", ")", "."], "sentence": "The fold enrichment in site occupancy was calculated incorporating IgG control values and input DNA values using the ChampionChIP qPCR data analysis file ( SA Biosciences ) .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["Quantification", "of", "cytokine", "levels", "."], "sentence": "Quantification of cytokine levels .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S129", "tokens": ["IL-4", ",", "IL-5", ",", "IL-6", ",", "IL-10", ",", "IL-13", ",", "IL-17", ",", "and", "IFN-gamma", "secretion", "was", "assessed", "using", "fluorescent", "bead-based", "technology", "."], "sentence": "IL-4 , IL-5 , IL-6 , IL-10 , IL-13 , IL-17 , and IFN-gamma secretion was assessed using fluorescent bead-based technology .", "event_mentions": [{"id": "E31", "event_type": "Localization", "trigger": {"text": "secretion", "start": 14, "end": 14}, "arguments": [{"entity_id": "T200", "text": "IL-4", "role": "Theme"}]}, {"id": "E32", "event_type": "Localization", "trigger": {"text": "secretion", "start": 14, "end": 14}, "arguments": [{"entity_id": "T201", "text": "IL-5", "role": "Theme"}]}, {"id": "E33", "event_type": "Localization", "trigger": {"text": "secretion", "start": 14, "end": 14}, "arguments": [{"entity_id": "T202", "text": "IL-6", "role": "Theme"}]}, {"id": "E34", "event_type": "Localization", "trigger": {"text": "secretion", "start": 14, "end": 14}, "arguments": [{"entity_id": "T203", "text": "IL-10", "role": "Theme"}]}, {"id": "E35", "event_type": "Localization", "trigger": {"text": "secretion", "start": 14, "end": 14}, "arguments": [{"entity_id": "T204", "text": "IL-13", "role": "Theme"}]}, {"id": "E36", "event_type": "Localization", "trigger": {"text": "secretion", "start": 14, "end": 14}, "arguments": [{"entity_id": "T205", "text": "IL-17", "role": "Theme"}]}, {"id": "E37", "event_type": "Localization", "trigger": {"text": "secretion", "start": 14, "end": 14}, "arguments": [{"entity_id": "T206", "text": "IFN-gamma", "role": "Theme"}]}], "entity_mentions": [{"id": "T200", "text": "IL-4", "entity_type": "Protein", "start": 0, "end": 0}, {"id": "T201", "text": "IL-5", "entity_type": "Protein", "start": 2, "end": 2}, {"id": "T202", "text": "IL-6", "entity_type": "Protein", "start": 4, "end": 4}, {"id": "T203", "text": "IL-10", "entity_type": "Protein", "start": 6, "end": 6}, {"id": "T204", "text": "IL-13", "entity_type": "Protein", "start": 8, "end": 8}, {"id": "T205", "text": "IL-17", "entity_type": "Protein", "start": 10, "end": 10}, {"id": "T206", "text": "IFN-gamma", "entity_type": "Protein", "start": 13, "end": 13}, {"id": "T275", "text": "secretion", "entity_type": "Localization", "start": 14, "end": 14}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["The", "Bio-Plex-hu", "Cytokine", "Panel", ",", "17-Plex", "Group", "1", "was", "used", "according", "to", "the", "manufacturer", "'s", "instructions", "(", "Bio-Rad", "Laboratories", ")", "."], "sentence": "The Bio-Plex-hu Cytokine Panel , 17-Plex Group 1 was used according to the manufacturer 's instructions ( Bio-Rad Laboratories ) .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["Fluorescent", "signals", "were", "read", "and", "analyzed", "using", "the", "Bio-Plex", "200", "System", "(", "Bio-Rad", "Laboratories", ")", "."], "sentence": "Fluorescent signals were read and analyzed using the Bio-Plex 200 System ( Bio-Rad Laboratories ) .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["Online", "supplemental", "material", "."], "sentence": "Online supplemental material .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S134", "tokens": ["Fig.S1", "shows", "the", "induction", "of", "RUNX1", ",", "RUNX3", ",", "and", "FOXP3", "mRNA", "in", "human", "CD4", "+", "T", "cells", "after", "anti", "-", "CD2", "/", "3", "/", "28", "mAb", "and", "TGF-beta", "stimulation", "."], "sentence": "Fig.S1 shows the induction of RUNX1 , RUNX3 , and FOXP3 mRNA in human CD4 + T cells after anti - CD2 / 3 / 28 mAb and TGF-beta stimulation .", "event_mentions": [{"id": "E38", "event_type": "Positive_regulation", "trigger": {"text": "induction", "start": 3, "end": 3}, "arguments": [{"entity_id": "T277", "text": "mRNA", "role": "Theme"}]}, {"id": "E40", "event_type": "Positive_regulation", "trigger": {"text": "induction", "start": 3, "end": 3}, "arguments": [{"entity_id": "T277", "text": "mRNA", "role": "Theme"}]}, {"id": "E42", "event_type": "Positive_regulation", "trigger": {"text": "induction", "start": 3, "end": 3}, "arguments": [{"entity_id": "T277", "text": "mRNA", "role": "Theme"}]}, {"id": "E39", "event_type": "Transcription", "trigger": {"text": "mRNA", "start": 11, "end": 11}, "arguments": [{"entity_id": "T207", "text": "RUNX1", "role": "Theme"}]}, {"id": "E41", "event_type": "Transcription", "trigger": {"text": "mRNA", "start": 11, "end": 11}, "arguments": [{"entity_id": "T208", "text": "RUNX3", "role": "Theme"}]}, {"id": "E43", "event_type": "Transcription", "trigger": {"text": "mRNA", "start": 11, "end": 11}, "arguments": [{"entity_id": "T209", "text": "FOXP3", "role": "Theme"}]}], "entity_mentions": [{"id": "T207", "text": "RUNX1", "entity_type": "Protein", "start": 5, "end": 5}, {"id": "T208", "text": "RUNX3", "entity_type": "Protein", "start": 7, "end": 7}, {"id": "T209", "text": "FOXP3", "entity_type": "Protein", "start": 10, "end": 10}, {"id": "T210", "text": "CD4", "entity_type": "Protein", "start": 14, "end": 14}, {"id": "T211", "text": "CD2", "entity_type": "Protein", "start": 21, "end": 21}, {"id": "T212", "text": "3", "entity_type": "Protein", "start": 23, "end": 23}, {"id": "T213", "text": "28", "entity_type": "Protein", "start": 25, "end": 25}, {"id": "T214", "text": "TGF-beta", "entity_type": "Protein", "start": 28, "end": 28}, {"id": "T276", "text": "induction", "entity_type": "Positive_regulation", "start": 3, "end": 3}, {"id": "T277", "text": "mRNA", "entity_type": "Transcription", "start": 11, "end": 11}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S136", "tokens": ["Fig.S2", "shows", "decreased", "RUNX1", "and", "RUNX3", "mRNA", "and", "protein", "expression", "after", "siRNA", "-", "mediated", "knockdown", "and", "decreased", "FOXP3", "expression", "in", "human", "CD4", "+", "T", "cells", "after", "RUNX1", "and", "RUNX3", "knockdown", "."], "sentence": "Fig.S2 shows decreased RUNX1 and RUNX3 mRNA and protein expression after siRNA - mediated knockdown and decreased FOXP3 expression in human CD4 + T cells after RUNX1 and RUNX3 knockdown .", "event_mentions": [{"id": "E44", "event_type": "Negative_regulation", "trigger": {"text": "decreased", "start": 2, "end": 2}, "arguments": [{"entity_id": "T279", "text": "mRNA", "role": "Theme"}, {"entity_id": "T281", "text": "knockdown", "role": "Cause"}]}, {"id": "E47", "event_type": "Negative_regulation", "trigger": {"text": "decreased", "start": 2, "end": 2}, "arguments": [{"entity_id": "T279", "text": "mRNA", "role": "Theme"}, {"entity_id": "T282", "text": "decreased", "role": "Cause"}]}, {"id": "E49", "event_type": "Negative_regulation", "trigger": {"text": "decreased", "start": 2, "end": 2}, "arguments": [{"entity_id": "T279", "text": "mRNA", "role": "Theme"}, {"entity_id": "T282", "text": "decreased", "role": "Cause"}]}, {"id": "E51", "event_type": "Negative_regulation", "trigger": {"text": "decreased", "start": 2, "end": 2}, "arguments": [{"entity_id": "T279", "text": "mRNA", "role": "Theme"}, {"entity_id": "T281", "text": "knockdown", "role": "Cause"}]}, {"id": "E53", "event_type": "Negative_regulation", "trigger": {"text": "decreased", "start": 2, "end": 2}, "arguments": [{"entity_id": "T279", "text": "mRNA", "role": "Theme"}, {"entity_id": "T282", "text": "decreased", "role": "Cause"}]}, {"id": "E54", "event_type": "Negative_regulation", "trigger": {"text": "decreased", "start": 2, "end": 2}, "arguments": [{"entity_id": "T279", "text": "mRNA", "role": "Theme"}, {"entity_id": "T282", "text": "decreased", "role": "Cause"}]}, {"id": "E45", "event_type": "Transcription", "trigger": {"text": "mRNA", "start": 6, "end": 6}, "arguments": [{"entity_id": "T215", "text": "RUNX1", "role": "Theme"}]}, {"id": "E52", "event_type": "Transcription", "trigger": {"text": "mRNA", "start": 6, "end": 6}, "arguments": [{"entity_id": "T216", "text": "RUNX3", "role": "Theme"}]}, {"id": "E55", "event_type": "Positive_regulation", "trigger": {"text": "mediated", "start": 13, "end": 13}, "arguments": [{"entity_id": "T281", "text": "knockdown", "role": "Theme"}]}, {"id": "E46", "event_type": "Negative_regulation", "trigger": {"text": "knockdown", "start": 14, "end": 14}, "arguments": [{"entity_id": "T283", "text": "expression", "role": "Theme"}]}, {"id": "E48", "event_type": "Negative_regulation", "trigger": {"text": "decreased", "start": 16, "end": 16}, "arguments": [{"entity_id": "T283", "text": "expression", "role": "Theme"}, {"entity_id": "T284", "text": "knockdown", "role": "Cause"}]}, {"id": "E50", "event_type": "Negative_regulation", "trigger": {"text": "decreased", "start": 16, "end": 16}, "arguments": [{"entity_id": "T283", "text": "expression", "role": "Theme"}, {"entity_id": "T284", "text": "knockdown", "role": "Cause"}]}, {"id": "E56", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 18, "end": 18}, "arguments": [{"entity_id": "T217", "text": "FOXP3", "role": "Theme"}]}, {"id": "E57", "event_type": "Negative_regulation", "trigger": {"text": "knockdown", "start": 29, "end": 29}, "arguments": [{"entity_id": "T219", "text": "RUNX1", "role": "Theme"}]}, {"id": "E58", "event_type": "Negative_regulation", "trigger": {"text": "knockdown", "start": 29, "end": 29}, "arguments": [{"entity_id": "T220", "text": "RUNX3", "role": "Theme"}]}], "entity_mentions": [{"id": "T215", "text": "RUNX1", "entity_type": "Protein", "start": 3, "end": 3}, {"id": "T216", "text": "RUNX3", "entity_type": "Protein", "start": 5, "end": 5}, {"id": "T217", "text": "FOXP3", "entity_type": "Protein", "start": 17, "end": 17}, {"id": "T218", "text": "CD4", "entity_type": "Protein", "start": 21, "end": 21}, {"id": "T219", "text": "RUNX1", "entity_type": "Protein", "start": 26, "end": 26}, {"id": "T220", "text": "RUNX3", "entity_type": "Protein", "start": 28, "end": 28}, {"id": "T278", "text": "decreased", "entity_type": "Negative_regulation", "start": 2, "end": 2}, {"id": "T279", "text": "mRNA", "entity_type": "Transcription", "start": 6, "end": 6}, {"id": "T280", "text": "mediated", "entity_type": "Positive_regulation", "start": 13, "end": 13}, {"id": "T281", "text": "knockdown", "entity_type": "Negative_regulation", "start": 14, "end": 14}, {"id": "T282", "text": "decreased", "entity_type": "Negative_regulation", "start": 16, "end": 16}, {"id": "T283", "text": "expression", "entity_type": "Gene_expression", "start": 18, "end": 18}, {"id": "T284", "text": "knockdown", "entity_type": "Negative_regulation", "start": 29, "end": 29}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S138", "tokens": ["Fig.S3", "shows", "the", "quantification", "of", "IL-4", ",", "IL-5", ",", "IL-10", ",", "IL-13", ",", "and", "IFN-gamma", "levels", "in", "control", "siRNA", "transfected", "or", "RUNX1", "and", "RUNX3", "siRNA", "transfected", "human", "CD4", "+", "T", "cells", "."], "sentence": "Fig.S3 shows the quantification of IL-4 , IL-5 , IL-10 , IL-13 , and IFN-gamma levels in control siRNA transfected or RUNX1 and RUNX3 siRNA transfected human CD4 + T cells .", "event_mentions": [{"id": "E59", "event_type": "Negative_regulation", "trigger": {"text": "siRNA", "start": 24, "end": 24}, "arguments": [{"entity_id": "T226", "text": "RUNX1", "role": "Theme"}]}, {"id": "E60", "event_type": "Negative_regulation", "trigger": {"text": "siRNA", "start": 24, "end": 24}, "arguments": [{"entity_id": "T227", "text": "RUNX3", "role": "Theme"}]}], "entity_mentions": [{"id": "T221", "text": "IL-4", "entity_type": "Protein", "start": 5, "end": 5}, {"id": "T222", "text": "IL-5", "entity_type": "Protein", "start": 7, "end": 7}, {"id": "T223", "text": "IL-10", "entity_type": "Protein", "start": 9, "end": 9}, {"id": "T224", "text": "IL-13", "entity_type": "Protein", "start": 11, "end": 11}, {"id": "T225", "text": "IFN-gamma", "entity_type": "Protein", "start": 14, "end": 14}, {"id": "T226", "text": "RUNX1", "entity_type": "Protein", "start": 21, "end": 21}, {"id": "T227", "text": "RUNX3", "entity_type": "Protein", "start": 23, "end": 23}, {"id": "T228", "text": "CD4", "entity_type": "Protein", "start": 27, "end": 27}, {"id": "T285", "text": "siRNA", "entity_type": "Negative_regulation", "start": 24, "end": 24}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S140", "tokens": ["Fig.S4", "shows", "the", "putative", "RUNX", "binding", "sites", "in", "the", "FOXP3", "core", "promoter", "sequence", "of", "human", ",", "mouse", ",", "and", "rat", "."], "sentence": "Fig.S4 shows the putative RUNX binding sites in the FOXP3 core promoter sequence of human , mouse , and rat .", "event_mentions": [], "entity_mentions": [{"id": "T229", "text": "FOXP3", "entity_type": "Protein", "start": 9, "end": 9}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S142", "tokens": ["Fig.S5", "shows", "the", "induction", "of", "FOXP3", "protein", "after", "overexpression", "of", "RUNX1", "and", "RUNX3", "in", "human", "CD4", "+", "T", "cells", "."], "sentence": "Fig.S5 shows the induction of FOXP3 protein after overexpression of RUNX1 and RUNX3 in human CD4 + T cells .", "event_mentions": [{"id": "E61", "event_type": "Positive_regulation", "trigger": {"text": "induction", "start": 3, "end": 3}, "arguments": [{"entity_id": "T230", "text": "FOXP3", "role": "Theme"}, {"entity_id": "T287", "text": "overexpression", "role": "Cause"}]}, {"id": "E63", "event_type": "Positive_regulation", "trigger": {"text": "induction", "start": 3, "end": 3}, "arguments": [{"entity_id": "T230", "text": "FOXP3", "role": "Theme"}, {"entity_id": "T287", "text": "overexpression", "role": "Cause"}]}, {"id": "E62", "event_type": "Gene_expression", "trigger": {"text": "overexpression", "start": 8, "end": 8}, "arguments": [{"entity_id": "T231", "text": "RUNX1", "role": "Theme"}]}, {"id": "E64", "event_type": "Gene_expression", "trigger": {"text": "overexpression", "start": 8, "end": 8}, "arguments": [{"entity_id": "T232", "text": "RUNX3", "role": "Theme"}]}], "entity_mentions": [{"id": "T230", "text": "FOXP3", "entity_type": "Protein", "start": 5, "end": 5}, {"id": "T231", "text": "RUNX1", "entity_type": "Protein", "start": 10, "end": 10}, {"id": "T232", "text": "RUNX3", "entity_type": "Protein", "start": 12, "end": 12}, {"id": "T233", "text": "CD4", "entity_type": "Protein", "start": 15, "end": 15}, {"id": "T286", "text": "induction", "entity_type": "Positive_regulation", "start": 3, "end": 3}, {"id": "T287", "text": "overexpression", "entity_type": "Gene_expression", "start": 8, "end": 8}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S144", "tokens": ["Fig.S6", "shows", "that", "endogenous", "IL-4", "and", "IFN-gamma", "do", "not", "effect", "Foxp3", "expression", "in", "naive", "CD4", "+", "T", "cells", "of", "Cbfb", "F", "/", "F", "CD4-cre", "and", "Cbfb", "F", "/", "F", "control", "mice", ",", "which", "were", "stimulated", "with", "anti", "-", "CD3", "and", "anti", "-", "CD28", "mAbs", ",", "IL-2", "and", "TGF-beta", "in", "the", "absence", "or", "presence", "of", "anti", "-", "IL-4", "and", "anti", "-", "IFN-gamma", "neutralizing", "mAbs", "."], "sentence": "Fig.S6 shows that endogenous IL-4 and IFN-gamma do not effect Foxp3 expression in naive CD4 + T cells of Cbfb F / F CD4-cre and Cbfb F / F control mice , which were stimulated with anti - CD3 and anti - CD28 mAbs , IL-2 and TGF-beta in the absence or presence of anti - IL-4 and anti - IFN-gamma neutralizing mAbs .", "event_mentions": [{"id": "E65", "event_type": "Regulation", "trigger": {"text": "effect", "start": 9, "end": 9}, "arguments": [{"entity_id": "T289", "text": "expression", "role": "Theme"}, {"entity_id": "T234", "text": "IL-4", "role": "Cause"}]}, {"id": "E67", "event_type": "Regulation", "trigger": {"text": "effect", "start": 9, "end": 9}, "arguments": [{"entity_id": "T289", "text": "expression", "role": "Theme"}, {"entity_id": "T235", "text": "IFN-gamma", "role": "Cause"}]}, {"id": "E66", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 11, "end": 11}, "arguments": [{"entity_id": "T236", "text": "Foxp3", "role": "Theme"}]}], "entity_mentions": [{"id": "T234", "text": "IL-4", "entity_type": "Protein", "start": 4, "end": 4}, {"id": "T235", "text": "IFN-gamma", "entity_type": "Protein", "start": 6, "end": 6}, {"id": "T236", "text": "Foxp3", "entity_type": "Protein", "start": 10, "end": 10}, {"id": "T237", "text": "CD4", "entity_type": "Protein", "start": 14, "end": 14}, {"id": "T238", "text": "Cbfb", "entity_type": "Protein", "start": 19, "end": 19}, {"id": "T239", "text": "CD4-cre", "entity_type": "Protein", "start": 23, "end": 23}, {"id": "T240", "text": "Cbfb", "entity_type": "Protein", "start": 25, "end": 25}, {"id": "T241", "text": "CD3", "entity_type": "Protein", "start": 38, "end": 38}, {"id": "T242", "text": "CD28", "entity_type": "Protein", "start": 42, "end": 42}, {"id": "T243", "text": "IL-2", "entity_type": "Protein", "start": 45, "end": 45}, {"id": "T244", "text": "TGF-beta", "entity_type": "Protein", "start": 47, "end": 47}, {"id": "T245", "text": "IL-4", "entity_type": "Protein", "start": 56, "end": 56}, {"id": "T246", "text": "IFN-gamma", "entity_type": "Protein", "start": 60, "end": 60}, {"id": "T288", "text": "effect", "entity_type": "Regulation", "start": 9, "end": 9}, {"id": "T289", "text": "expression", "entity_type": "Gene_expression", "start": 11, "end": 11}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S146", "tokens": ["Fig.S7", "shows", "similar", "cell", "death", "(", "A", ")", "and", "proliferation", "(", "B", ")", "of", "Foxp3", "+", "and", "Foxp3", "-", "cells", "in", "Cbfb", "F", "/", "F", "CD4", "-", "cre", "and", "Cbfb", "F", "/", "F", "control", "mice", "cultures", "."], "sentence": "Fig.S7 shows similar cell death ( A ) and proliferation ( B ) of Foxp3 + and Foxp3 - cells in Cbfb F / F CD4 - cre and Cbfb F / F control mice cultures .", "event_mentions": [], "entity_mentions": [{"id": "T247", "text": "Foxp3", "entity_type": "Protein", "start": 14, "end": 14}, {"id": "T248", "text": "Foxp3", "entity_type": "Protein", "start": 17, "end": 17}, {"id": "T249", "text": "Cbfb", "entity_type": "Protein", "start": 21, "end": 21}, {"id": "T250", "text": "CD4", "entity_type": "Protein", "start": 25, "end": 25}, {"id": "T251", "text": "cre", "entity_type": "Protein", "start": 27, "end": 27}, {"id": "T252", "text": "Cbfb", "entity_type": "Protein", "start": 29, "end": 29}]}
{"doc_id": "PMC-2806624-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["Online", "supplemental", "material", "is", "available", "at", "http", ":", "/", "/", "www.jem.org", "/", "cgi", "/", "content", "/", "full", "/", "jem.20090596", "/", "DC1", "."], "sentence": "Online supplemental material is available at http : / / www.jem.org / cgi / content / full / jem.20090596 / DC1 .", "event_mentions": [], "entity_mentions": []}
